| Spot |
Coordinate |
P |
Ratio |
SE |
Gene Name |
| 764 |
D13h |
0.00015865 |
1.9015 |
0.011356 |
angiopoietin 1 receptor precursor; tyrosine-protein kinase receptor TIE-2; tyrosine-protein kinase receptor TEK; p140 TEK; tunica interna endothelial cell kinase |
| 570 |
C13j |
0.0006393 |
0.62641 |
0.0094506 |
transcription factor Sp1 (TSFP1) |
| 858 |
E06d |
0.00083246 |
0.66087 |
0.0097909 |
growth-arrest-specific protein (GAS) |
| 1128 |
F11h |
0.001337 |
0.67249 |
0.011988 |
CRM1 protein |
| 1092 |
F08n |
0.0014705 |
0.29165 |
0.027194 |
BRCA2 region clone CG018 |
| 1050 |
F05n |
0.0014818 |
0.39571 |
0.023288 |
inducible protein |
| 4 |
A01d |
0.0018953 |
1.3663 |
0.015971 |
jun-B |
| 750 |
D12h |
0.0023235 |
1.508 |
0.02453 |
vascular endothelial growth factor receptor 2 precursor (VEGFR2); kinase insert domain receptor (KDR); FLK1 |
| 1021 |
F03m |
0.0026433 |
0.59835 |
0.020691 |
HEM45 |
| 1138 |
F12d |
0.0027066 |
0.66671 |
0.017375 |
uridine 5'-monophosphate synthase (UMP synthase) |
| 1154 |
F13f |
0.0028389 |
0.33967 |
0.035259 |
type II cytoskeletal 4 keratin (KRT4); cytokeratin 4 (K4; CK4) |
| 771 |
D14a |
0.0030655 |
0.71678 |
0.015717 |
CENP-F kinetochore protein |
| 1085 |
F08g |
0.0032744 |
1.6288 |
0.036071 |
tubulin gamma subunit |
| 1008 |
F02n |
0.0034392 |
0.57964 |
0.024716 |
KIAA0137 |
| 479 |
C07c |
0.0040484 |
0.71228 |
0.018363 |
induced myeloid leukemia cell differentiation protein MCL-1 |
| 249 |
B04k |
0.0054851 |
0.42091 |
0.043066 |
caveolin-1 |
| 1166 |
F14d |
0.0056179 |
0.47424 |
0.039574 |
thymidylate kinase |
| 620 |
D03d |
0.0056411 |
0.78035 |
0.016567 |
cadherin 11 precursor (CDH11); osteoblast-cadherin (OB-cadherin); OSF4 |
| 852 |
E05l |
0.0057743 |
1.1124 |
0.0085787 |
alpha-2-macroglobulin precursor (alpha-2-M) |
| 1155 |
F13g |
0.006178 |
0.67065 |
0.026008 |
coronin-like protein P57 |
| 266 |
B05n |
0.0069441 |
0.68651 |
0.02626 |
signal transducing adaptor molecule (STAM) |
| 967 |
E14a |
0.0069656 |
0.41791 |
0.048837 |
transforming growth factor beta2 precursor (TGF-beta2; TGFB2); glioblastoma -derived T-cell suppressor factor (G-TSF); bsc-1 cell growth inhibitor; polyergin; cetermin |
| 587 |
C14m |
0.0074805 |
0.60146 |
0.034664 |
fuse-binding protein 2 (FBP2) |
| 767 |
D13k |
0.0078704 |
1.1407 |
0.012553 |
butyrophilin precursor (BT) |
| 226 |
B03b |
0.0081712 |
1.4178 |
0.038005 |
alpha-2-macroglobulin receptor-associated protein precursor (alpha-2-MRAP; A2MRAP); low density lipoprotein receptor-related protein- associated protein 1 (LRPAP1) |
| 182 |
A13n |
0.0084942 |
0.76675 |
0.021636 |
nucleolar phosphoprotein P130 |
| 191 |
A14i |
0.0091736 |
1.8792 |
0.084796 |
G1/S-specific cyclin C |
| 1019 |
F03k |
0.009201 |
0.71139 |
0.027877 |
regulator of G protein signaling 3 (RGS3; RGP3) |
| 1101 |
F09i |
0.0097994 |
0.48504 |
0.051355 |
arginine/serine-rich splicing factor 8; suppressor of white apricot protein homolog |
| 1157 |
F13i |
0.010136 |
0.51381 |
0.049323 |
polypyrimidine tract-binding protein (PTB); heterogeneous nuclear ribonucleoprotein I (HNRNP I); 57-kDa RNA-binding protein PPTB-1 |
| 886 |
E08d |
0.01081 |
0.47336 |
0.055204 |
platelet basic protein precursor (PBP); connective tissue activating peptide III (CTAP III); low-affinity platelet factor IV (LA PF4); beta thromboglobulin (beta TG); neutrophil activating peptide 2 (NAP2) |
| 33 |
A03e |
0.011071 |
1.9112 |
0.096677 |
vascular endothelial growth factor receptor 1 (VEGFR1); tyrosine-protein kinase receptor flt + soluble VEGFR; tyrosine-protein kinase receptor SFLT |
| 617 |
D03a |
0.011986 |
1.4171 |
0.04608 |
Ikaros/LyF-1 homolog hIk-1 |
| 1177 |
G11 |
0.012043 |
1.3102 |
0.034352 |
ubiquitin |
| 489 |
C07m |
0.0123 |
0.76317 |
0.02651 |
adenovirus E1A enhancer-binding protein; E1A-F; ets translocation variant 4 |
| 990 |
F01j |
0.012647 |
0.75886 |
0.027379 |
putative RNA-binding protein KOC |
| 909 |
E09m |
0.013699 |
0.73817 |
0.030965 |
membrane-bound & secreted immunoglobulin gamma heavy chain (IgG3) + immunoglobulin lambda heavy chain (IgG1L) + immunoglobulin kappa heavy chain (IgG1K) + immunoglobulin G1 Fc fragment (IgG1) |
| 760 |
D13d |
0.014782 |
0.53928 |
0.056644 |
platelet membrane glycoprotein IIIA precursor (GP3A); integrin beta 3 (ITGB3); CD61 antigen |
| 322 |
B09n |
0.015413 |
0.79124 |
0.026222 |
CD27 ligand (CD27LG); CD70 antigen |
| 431 |
C03k |
0.016449 |
0.85705 |
0.018563 |
TRAF-interacting protein (I-TRAF) + TRAF family member-associated NF-kappaB activator TANK |
| 1142 |
F12h |
0.017037 |
0.61212 |
0.051285 |
importin alpha 3 subunit; karyopherin alpha 3 subunit |
| 417 |
C02k |
0.018045 |
0.64209 |
0.048741 |
ets transcription factor; NERF2 |
| 217 |
B02g |
0.018056 |
1.121 |
0.01649 |
3-phosphoinositide-dependent protein kinase 1 (PDK1) |
| 1104 |
F09l |
0.018424 |
0.63987 |
0.04957 |
KIAA0231 |
| 413 |
C02g |
0.018656 |
1.1668 |
0.023104 |
DNA ligase III (LIG3); polydeoxyribonucleotide synthase |
| 307 |
B08m |
0.019295 |
0.79211 |
0.029303 |
segment polarity protein; dishevelled homolog 1 (DSH homolog 1); dishevelled 1 (DVL1) |
| 16 |
A02b |
0.020129 |
1.5444 |
0.078424 |
EB1 protein |
| 828 |
E04b |
0.020284 |
0.47602 |
0.075783 |
hepatoma-derived growth factor (HDGF) |
| 844 |
E05d |
0.020285 |
0.53862 |
0.066732 |
thymus-expressed chemokine precursor (TECK) |
| 23 |
A02i |
0.021013 |
1.6593 |
0.097115 |
probable G protein-coupled receptor KIAA0001 |
| 383 |
B14e |
0.021473 |
1.3528 |
0.052541 |
VRK2 |
| 1077 |
F07m |
0.021979 |
0.81082 |
0.028519 |
interferon-inducible protein 1-8D + 1-8U |
| 809 |
E02k |
0.022362 |
1.3865 |
0.058794 |
PC8 precursor |
| 687 |
D08a |
0.022695 |
0.63862 |
0.055389 |
high mobility group protein (HMG-I) |
| 1116 |
F10j |
0.024209 |
0.3265 |
0.10674 |
suppressor for yeast mutant |
| 1037 |
F05a |
0.02545 |
0.53735 |
0.075252 |
laminin alpha 4 subunit precursor (laminin A4; LAMA4) |
| 1132 |
F11l |
0.026373 |
0.45316 |
0.090606 |
ATL-derived PMA-responsive peptide (APR) |
| 1140 |
F12f |
0.026543 |
0.36924 |
0.10486 |
type II cytoskeletal 2 epidermal keratin (KRT2E); cytokeratin 2E (K2E; CK2E) |
| 1158 |
F13j |
0.026573 |
0.62252 |
0.062792 |
elongation factor 2 (EF2) |
| 953 |
E13a |
0.02659 |
0.77114 |
0.038082 |
transforming growth factor-beta (TGF-beta; TGFB) |
| 47 |
A04e |
0.028231 |
1.3207 |
0.055057 |
tyrosine-protein kinase receptor tyro3 precursor; rse; sky; dtk |
| 470 |
C06h |
0.028235 |
0.77683 |
0.038316 |
RecQ protein-like (DNA helicase Q1-like) |
| 529 |
C10k |
0.028387 |
0.62037 |
0.065361 |
signal transducer and activator of transcription 3 (STAT3); acute-phase response factor (APRF) |
| 861 |
E06g |
0.02839 |
0.66839 |
0.057098 |
interleukin-15 (IL-15) |
| 1107 |
F10a |
0.029088 |
0.60807 |
0.068345 |
nidogen precursor (NID); entactin |
| 1097 |
F09e |
0.029655 |
0.5979 |
0.070829 |
adenylosuccinate synthetase; IMP-aspartate ligase |
| 612 |
D02j |
0.029765 |
1.4841 |
0.085446 |
trk-T3; P68 TRK-T3 oncoprotein |
| 685 |
D07m |
0.030499 |
1.922 |
0.16481 |
glutathione synthetase (GSH synthetase; GSH-S); glutathione synthase |
| 720 |
D10f |
0.030804 |
0.63285 |
0.065973 |
zyxin related protein ZRP-1 |
| 27 |
A02m |
0.030838 |
0.84213 |
0.028384 |
NuMA |
| 691 |
D08e |
0.0315 |
0.54682 |
0.082392 |
integrin alpha 7B precursor (IGA7B) |
| 1129 |
F11i |
0.031516 |
0.72332 |
0.050315 |
cleavage stimulation factor 77-kDa subunit |
| 857 |
E06c |
0.032938 |
0.69008 |
0.057682 |
vascular endothelial growth factor C precursor (VEGF-C); vascular endothelial growth factor related protein (VRP); FLT4 ligand |
| 719 |
D10e |
0.033601 |
0.71525 |
0.053555 |
semaphorin; CD100 |
| 890 |
E08h |
0.033743 |
0.7393 |
0.049142 |
jagged 1 (HJ1) |
| 731 |
D11c |
0.033967 |
1.1074 |
0.020307 |
T-cell surface glycoprotein CD3 epsilon subunit precursor; T-cell surface antigen T3/leu-4 epsilon subunit (T3E) |
| 1133 |
F11m |
0.034073 |
0.34461 |
0.12417 |
unknown protein expressed in macrophages |
| 1029 |
F04g |
0.034215 |
1.3144 |
0.059689 |
vimentin (VIM) |
| 995 |
F02a |
0.034735 |
0.58328 |
0.079757 |
collagen 11 alpha 2 subunit (COL11A2) |
| 903 |
E09g |
0.034918 |
0.72638 |
0.052515 |
interleukin-16 (IL-16); lymphocyte chemoattractant factor (LCF) |
| 195 |
A14m |
0.034966 |
0.55556 |
0.085363 |
RBQ-3 |
| 1012 |
F03d |
0.03549 |
0.64699 |
0.068334 |
thymidylate synthase (TYMS; TS) |
| 845 |
E05e |
0.036524 |
0.5108 |
0.096146 |
interleukin-1 receptor antagonist protein precursor (IL-1RA; IRAP) |
| 849 |
E05i |
0.036681 |
2.7655 |
0.34779 |
matrix metalloproteinase 1 (MMP1); interstitial collagenase precursor (CLG); fibroblast collagenase |
| 956 |
E13d |
0.038396 |
0.54173 |
0.092482 |
fibroblast growth factor 6 precursor (FGF6); HBGF6; HST2 |
| 1067 |
F07c |
0.038453 |
0.66226 |
0.068212 |
amidophosphoribosyltransferase precursor (ATase); glutamine phosphoribosylpyrophosphate amidotransferase (GPAT) |
| 713 |
D09m |
0.038498 |
1.591 |
0.11944 |
glutathione-S-transferase (GST) homolog |
| 239 |
B04a |
0.0386 |
1.7404 |
0.14984 |
ATP synthase coupling factor 6 mitochondrial precursor (F6) |
| 932 |
E11h |
0.038641 |
0.39268 |
0.12298 |
lunatic fringe |
| 379 |
B14a |
0.038702 |
1.2441 |
0.049475 |
integrin-linked kinase (ILK) |
| 1105 |
F09m |
0.040559 |
0.65969 |
0.070706 |
hypothetical 120.4-kDa protein |
| 957 |
E13e |
0.040922 |
0.43965 |
0.11698 |
CD30 ligand (CD30L); CD153 antigen |
| 404 |
C01l |
0.041316 |
0.77934 |
0.0463 |
zinc finger 5 protein |
| 811 |
E02m |
0.041659 |
0.47687 |
0.11025 |
MHC class I truncated HLA G lymphocyte antigen + HLA class I histocompability antigen AW-80(A-1) alpha chain precursor + MHC class I antigen HLA-B + MHC class I antigen HLA-C |
| 173 |
A13e |
0.041954 |
1.4845 |
0.10248 |
transforming protein rhoA H12 (RHO12; ARH12; ARHA) |
| 855 |
E06a |
0.042752 |
0.36369 |
0.13597 |
bone morphogenetic protein 4 (BMP4) + bone morphogenetic protein 2B (BMP2B) |
| 758 |
D13b |
0.043076 |
0.77976 |
0.047251 |
platelet glycoprotein IV (GPIV; PAS IV; PAS4); GPIIIB; CD36 antigen |
| 78 |
A06h |
0.043191 |
1.4091 |
0.087897 |
notch4; hnotch4 |
| 662 |
D06d |
0.043331 |
1.1721 |
0.037037 |
integrin alpha E precursor (ITGAE); mucosal lymphocyte-1 antigen; hml-1 antigen; CD103 antigen |
| 1176 |
F14n |
0.043778 |
0.51012 |
0.10601 |
antigen KI-67 (MKI67) |
| 252 |
B04n |
0.043832 |
0.63885 |
0.078206 |
B-cell receptor-associated protein (hBAP) |
| 402 |
C01j |
0.044566 |
0.73537 |
0.057816 |
ets domain protein elk-3; NET; SRF accessory protein 2 (SAP2) |
| 929 |
E11e |
0.044749 |
0.68094 |
0.069861 |
SCGF-beta |
| 991 |
F01k |
0.045141 |
0.86294 |
0.030152 |
60S ribosomal protein L10; tumor suppressor QM; laminin receptor homolog |
| 734 |
D11f |
0.045435 |
0.72698 |
0.06027 |
ninjurin-1 |
| 1072 |
F07h |
0.046355 |
1.1794 |
0.040022 |
GTP-binding nuclear protein RAN (TC4) |
| 1152 |
F13d |
0.046876 |
0.64359 |
0.080006 |
adenylate kinase isoenzyme 1 (AK1); ATP-AMP transphosphorylase; myokinase |
| 653 |
D05i |
0.047073 |
0.79186 |
0.046828 |
fibroblast growth factor receptor 3 precursor (FGFR3); JTK4 + fibroblast growth factor receptor 2 precursor (FLG2) |
| 1169 |
F14g |
0.047463 |
0.52671 |
0.10696 |
microtubule-associated protein 1B |
| 1114 |
F10h |
0.04756 |
0.59387 |
0.09188 |
dual-specificty A-kinase anchoring protein 1 |
| 121 |
A09i |
0.048128 |
1.7841 |
0.17852 |
G1/S-specific cyclin E (CCNE) |
| 1121 |
F11a |
0.048181 |
0.59416 |
0.092459 |
tenascin precursor (TN); hexabrachion (HXB); cytotactin; neuronectin; GMEM; miotendinous antigen; glioma-associated extracellular matrix antigen |
| 707 |
D09g |
0.04883 |
0.8305 |
0.038894 |
protocadherin 43 precursor (PCDH43); cadherin-like protein |
| 805 |
E02g |
0.048897 |
0.63606 |
0.083574 |
interleukin-14 precursor (IL-14); high molecular weight B-cell growth factor (HMW-BCGF) |
| 882 |
E07n |
0.049925 |
0.69362 |
0.071149 |
procollagen 2 alpha 1 subunit precursor (COL2A1) |
| 240 |
B04b |
0.050206 |
1.4337 |
0.10103 |
APS |
| 1134 |
F11n |
0.05022 |
0.37372 |
0.1459 |
MYD88 |
| 919 |
E10i |
0.050759 |
0.51903 |
0.1127 |
matrix metalloproteinase 9 (MMP9); gelatinase B; 92-kDa type IV collagenase precursor (CLG4B) |
| 842 |
E05b |
0.050953 |
0.51612 |
0.11361 |
endothelin 3 (EDN3; ET3) |
| 490 |
C07n |
0.050999 |
0.58826 |
0.096724 |
AP4 basic helix-loop-helix DNA-binding protein |
| 642 |
D04l |
0.05144 |
1.9288 |
0.21921 |
low-density lipoprotein receptor-related protein LR11 precursor |
| 1170 |
F14h |
0.052577 |
0.71108 |
0.069 |
nuclear pore complex protein 153 (NUP153); 153-kDa nucleoporin |
| 185 |
A14c |
0.052598 |
1.6606 |
0.15779 |
ets-related protein tel; ets translocation variant 6 (ETV6) |
| 158 |
A12d |
0.052738 |
1.4973 |
0.11897 |
epidermal growth factor receptor (EGFR) |
| 339 |
B11c |
0.053187 |
1.1145 |
0.027507 |
C-jun N-terminal kinase 3 alpha2 (JNK3A2); PRKM10 + MAP kinase p493F12 |
| 532 |
C10n |
0.053349 |
0.66711 |
0.080132 |
myeloid ELF1-like factor |
| 35 |
A03g |
0.054322 |
1.2187 |
0.053165 |
c-myc binding protein MM-1 |
| 780 |
D14j |
0.054325 |
1.8538 |
0.20754 |
interleukin-13 receptor |
| 569 |
C13i |
0.05465 |
0.65819 |
0.083364 |
hypoxia-inducible factor 1 alpha (HIF1 alpha); ARNT-interacting protein; member of PAS protein 1 (MOP1) |
| 510 |
C09f |
0.054887 |
0.63889 |
0.088277 |
DNA topoisomerase II beta (TOP2B) |
| 45 |
A04c |
0.054954 |
1.6416 |
0.15696 |
c-rel proto-oncogene protein |
| 813 |
E03a |
0.055149 |
0.65942 |
0.083474 |
bone morphogenetic protein 1 (BMP1) + procollagen C-proteinase (pCP-2) |
| 1118 |
F10l |
0.055405 |
0.47104 |
0.12997 |
KIAA0265 |
| 674 |
D07b |
0.056834 |
0.57578 |
0.10569 |
high mobility group protein HMG2 |
| 1044 |
F05h |
0.056999 |
1.2638 |
0.065818 |
interferon-regulated resistance GTP-binding protein MXA (IFI-78K); interferon- induced protein P78 |
| 370 |
B13f |
0.057013 |
0.88897 |
0.02771 |
serine kinase SRPK2 |
| 546 |
C11n |
0.057143 |
0.54868 |
0.11278 |
transcription factor HGATA-6 |
| 294 |
B07n |
0.058007 |
0.5411 |
0.11562 |
fas antigen ligand (FASL); apoptosis antigen ligand (APTL; APT1LG1); TNFSF6 |
| 851 |
E05k |
0.059349 |
1.7356 |
0.18765 |
oxytocinase; cystinyl aminopeptidase |
| 170 |
A13b |
0.059975 |
1.2795 |
0.071714 |
p78 putative serine/threonine-protein kinase |
| 123 |
A09k |
0.060124 |
0.92294 |
0.0198 |
CDC-like kinase 3 (CLK3) |
| 1036 |
F04n |
0.060597 |
0.67499 |
0.083867 |
KIAA0279 |
| 140 |
A10n |
0.061553 |
0.63461 |
0.0951 |
btg protein precursor; NGF-inducible anti-proliferative protein PC3 |
| 884 |
E08b |
0.061775 |
0.54827 |
0.11781 |
amphiregulin (AR); colorectum cell-derived growth factor (CRDGF) |
| 1131 |
F11k |
0.062634 |
0.5707 |
0.11281 |
ribosomal protein S21 (RPS21) |
| 416 |
C02j |
0.063421 |
0.69657 |
0.080284 |
RBP2 retinoblastoma binding protein |
| 1110 |
F10d |
0.063943 |
0.60943 |
0.10381 |
ribonucleoside-diphosphate reductase M1 subunit; ribonucleotide reductase |
| 712 |
D09l |
0.06431 |
1.5849 |
0.15595 |
protein tyrosine phosphatase |
| 508 |
C09d |
0.06474 |
0.76375 |
0.063224 |
ionizing radiation resistance-conferring protein + death-associated protein 3 (DAP3) |
| 901 |
E09e |
0.065112 |
0.49487 |
0.13561 |
macrophage inhibitory cytokine 1 (MIC1) |
| 367 |
B13c |
0.065425 |
1.1501 |
0.040401 |
histamine H1 receptor (HRH1) |
| 1026 |
F04d |
0.065726 |
1.522 |
0.14087 |
purine nucleoside phosphorylase (PNP); inosine phosphorylase |
| 969 |
E14c |
0.065912 |
0.56161 |
0.11849 |
glia maturation factor beta (GMF-beta) |
| 474 |
C06l |
0.066215 |
0.84057 |
0.043201 |
signal transducer and transcription activator 5A (STAT5A) + signal transducer and transcription activator 5B (STAT5B) |
| 475 |
C06m |
0.066526 |
0.64119 |
0.09748 |
B4-2 protein |
| 588 |
C14n |
0.066959 |
0.7446 |
0.069636 |
transcription factor erf-1; AP2 gamma transcription factor |
| 756 |
D12n |
0.067179 |
0.81715 |
0.049946 |
semaphorin E |
| 963 |
E13k |
0.067523 |
0.60777 |
0.10744 |
tissue-type plasminogen activator precursor (T-plasminogen activator; TPA) |
| 448 |
C04n |
0.06767 |
1.5532 |
0.15171 |
PIRIN |
| 906 |
E09j |
0.067816 |
1.4347 |
0.11937 |
placental plasminogen activator inhibitor 2 (PAI-2; PLANH2); monocyte ARG-serpin; urokinase inhibitor |
| 518 |
C09n |
0.068464 |
0.8109 |
0.052197 |
acid finger protein |
| 934 |
E11j |
0.069487 |
0.81434 |
0.051672 |
tissue inhibitor of metalloproteinases 2 (TIMP2); metalloproteinase inhibitor 2 precursor; CSC-21K |
| 911 |
E10a |
0.07073 |
0.67472 |
0.091433 |
bone-derived growth factor 1 (BPGF1) |
| 972 |
E14f |
0.071604 |
0.63189 |
0.10418 |
interleukin-10 precursor (IL-10); cytokine synthesis inhibitory factor (CSIF) |
| 1109 |
F10c |
0.072214 |
0.56304 |
0.12426 |
inosine-5'-monophosphate dehydrogenase 2 (IMP dehydrogenase 2; IMPD2) |
| 115 |
A09c |
0.07257 |
1.3539 |
0.10093 |
jun-D |
| 30 |
A03b |
0.073371 |
0.79335 |
0.05929 |
ezrin; cytovillin 2; villin 2 (VIL2) |
| 1054 |
F06d |
0.073417 |
0.80442 |
0.056133 |
L-lactate dehydrogenase H subunit (LDHB) |
| 601 |
D01m |
0.073635 |
1.2621 |
0.075335 |
transmembrane protein sex precursor |
| 488 |
C07l |
0.073923 |
0.80966 |
0.054839 |
CHD3 |
| 145 |
A11e |
0.074703 |
2.177 |
0.34112 |
C-fgr proto-oncogene (p55-FGR); SRC2 |
| 476 |
C06n |
0.074811 |
0.54236 |
0.13274 |
interferon regulatory factor 3 (IRF3) |
| 711 |
D09k |
0.075243 |
1.7004 |
0.2038 |
eph-family protein |
| 1185 |
G47 |
0.076653 |
0.50219 |
0.14638 |
40S ribosomal protein S9 |
| 1040 |
F05d |
0.07668 |
0.65105 |
0.10263 |
L-lactate dehydrogenase M subunit (LDHA) |
| 1130 |
F11j |
0.076801 |
0.6084 |
0.11527 |
eukaryotic translation initiation factor 4E 25-kDa subunit (EIF4E); mRNA cap-binding protein |
| 1126 |
F11f |
0.077053 |
0.77348 |
0.066802 |
type II cytoskeletal 2 oral keratin; cytokeratin 2P (K2P; CK2P) |
| 1035 |
F04m |
0.077711 |
0.71485 |
0.084498 |
polyhomeotic 2 homolog (HPH2) |
| 692 |
D08f |
0.078175 |
0.62734 |
0.1108 |
paxillin |
| 654 |
D05j |
0.078238 |
0.69266 |
0.09142 |
interferon-alpha/beta receptor beta subunit precursor (IFN-alpha-R); type I interferon receptor (IFN-R) |
| 785 |
E01a |
0.078786 |
0.6181 |
0.11405 |
semaphorin-1 |
| 989 |
F01i |
0.079083 |
0.84706 |
0.045769 |
nuclear pore complex protein 358 (NUP153); 358-kDa nucleoporin; RAN-binding protein 2 |
| 211 |
B02a |
0.080024 |
1.3074 |
0.092625 |
ADP/ATP carrier protein |
| 280 |
B06n |
0.080252 |
0.66936 |
0.099773 |
CD40 ligand (CD40-L); tumor necrosis factor (TNF)-related activation protein (TRAP); T-cell antigen GP39 |
| 1103 |
F09k |
0.081368 |
0.69166 |
0.093776 |
aspartyl-tRNA synthetase (ASPRS); aspartate-tRNA ligase |
| 753 |
D12k |
0.083632 |
0.58035 |
0.12964 |
G protein-coupled receptor GPR-NGA |
| 231 |
B03g |
0.083694 |
1.805 |
0.24877 |
serum- & glucocorticoid-regulated serine/threonine protein kinase (SGK) |
| 702 |
D09b |
0.084123 |
1.9898 |
0.30678 |
nuclear protein |
| 1055 |
F06e |
0.086354 |
1.1874 |
0.058962 |
trifunctional purine biosynthetic protein adenosine 3 |
| 134 |
A10h |
0.086652 |
1.9819 |
0.30954 |
von Hippel-Lindau-binding protein 1 (HIBBJ46; VHL-binding protein 1; VBP1) |
| 945 |
E12g |
0.086977 |
0.72801 |
0.085924 |
eph-related receptor tyrosine kinase ligand 1 precursor (EPGL1); LERK-1; immediate early response protein B61; tumor necrosis factor-alpha (TNF-alpha)-induced protein 4 (TNFAIP4) |
| 19 |
A02e |
0.08719 |
1.4278 |
0.13533 |
platelet-derived growth factor receptor alpha subunit (PDGFRA); CD140A antigen |
| 574 |
C13n |
0.087459 |
0.51535 |
0.15359 |
basic-leucine zipper transcription factor MAFG |
| 710 |
D09j |
0.087492 |
0.64063 |
0.11391 |
G protein-coupled receptor EDG4 |
| 988 |
F01h |
0.087501 |
0.82021 |
0.056992 |
erythrocyte spectrin alpha subunit |
| 799 |
E02a |
0.087572 |
0.52574 |
0.15041 |
bone morphogenetic protein 3B precursor (BMP3B); growth differentiation factor 10 (GDF10); bone inducing protein (BIP) |
| 1096 |
F09d |
0.088241 |
0.73646 |
0.083946 |
5'-nucleotidase precurso (5'-NT)r; ecto-nucleotidase; CD73 antigen |
| 936 |
E11l |
0.088681 |
1.4616 |
0.14747 |
CD59 glycoprotein precursor; membrane attack complex inhibition factor (MACIF); MAC inhibitory protein (MACIP); MEM43 antigen; protectin; membrane inhibitor of reactive lysis (MIRL); HRF20; 1F5 antigen |
| 350 |
B11n |
0.088778 |
0.5844 |
0.13285 |
secreted apoptosis related protein 1 (SARP1) |
| 535 |
C11c |
0.089841 |
1.1455 |
0.046841 |
Fas-activated serine/threonine (FAST) kinase |
| 1032 |
F04j |
0.090977 |
1.2834 |
0.09187 |
cofactor C |
| 449 |
C05a |
0.092758 |
0.60337 |
0.13002 |
death receptor 5 (DR5); cytotoxic TRAIL receptor 2 (TRICK2A) |
| 832 |
E04f |
0.093515 |
0.48246 |
0.17046 |
interleukin-7 (IL-7) |
| 251 |
B04m |
0.094073 |
0.74288 |
0.084979 |
SH3P17 SH3 domain-containing protein |
| 491 |
C08a |
0.094719 |
1.8064 |
0.26759 |
receptor interacting protein; serine/threonine protein kinase RIP transferase; serine/threonine-protein kinase ATP-binding apoptosis; cell death protein RIP |
| 1099 |
F09g |
0.095447 |
1.5977 |
0.19923 |
gravin |
| 17 |
A02c |
0.097258 |
1.3652 |
0.12306 |
myb proto-oncogene; c-myb |
| 436 |
C04b |
0.097835 |
0.95553 |
0.015035 |
tumor necrosis factor type 1 receptor associated protein (TRAP1) |
| 79 |
A06i |
0.099225 |
1.5274 |
0.17979 |
G1/S-specific cyclin D1 (CCND1); cyclin PRAD1; bcl-1 oncogene |
| 808 |
E02j |
0.099503 |
1.7947 |
0.27138 |
microsomal aminopeptidase N; myeloid plasma membrane glycoprotein CD13 |
| 639 |
D04i |
0.10001 |
0.61582 |
0.13158 |
ephrin type-A receptor 2 precursor; epithelial cell kinase (ECK); tyrosine-protein kinase receptor ECK |
| 598 |
D01j |
0.10016 |
2.0158 |
0.34821 |
patched homolog (PTC) |
| 224 |
B02n |
0.1007 |
0.64831 |
0.12093 |
pituitary adenylate cyclase activating polypeptide I receptor precursor (PACAP I receptor; PACAPR1; ADCYAP1R1) |
| 659 |
D06a |
0.10116 |
0.69773 |
0.10422 |
guanine nucleotide-binding protein G(Y) alpha 11 subunit (GNA11; GA11) |
| 983 |
F01c |
0.10123 |
1.2035 |
0.0702 |
uroporphyringen III synthase |
| 525 |
C10g |
0.10169 |
1.1484 |
0.051307 |
DNA mismatch repair protein PMS1 (PMS1 protein homolog 1) |
| 536 |
C11d |
0.10184 |
1.2719 |
0.094113 |
inhibitor of apoptosis protein 2 (HIAP2; IAP2) + IAP homolog B; TNFR2-TRAF signalling complex protein 2; MIHB |
| 876 |
E07h |
0.10211 |
0.53368 |
0.16167 |
macrophage migration inhibitory factor (MIF); glycosylation-inhibiting factor (GIF) |
| 607 |
D02e |
0.1026 |
1.3061 |
0.10641 |
integrin beta 6 precursor (ITGB6) |
| 159 |
A12e |
0.10355 |
1.7576 |
0.26481 |
shb proto-oncogene |
| 1102 |
F09j |
0.1044 |
0.53976 |
0.16165 |
"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase; beta-galactoside alpha-2,3-sialyltransferase (alpha-2,3-ST); sialyltransferase 4A (SIAT4A)" |
| 142 |
A11b |
0.10533 |
1.2615 |
0.09233 |
TSG101 tumor susceptibility protein |
| 484 |
C07h |
0.10542 |
0.72063 |
0.098687 |
KIAA0078 |
| 1069 |
F07e |
0.10563 |
0.6081 |
0.1386 |
ribonucleoside-diphosphate reductase M2 subunit; ribonucleotide reductase |
| 594 |
D01f |
0.10579 |
1.4251 |
0.15047 |
RP105 |
| 1006 |
F02l |
0.10624 |
0.54856 |
0.1602 |
leukocyte interferon-inducible peptide |
| 626 |
D03j |
0.10758 |
2.1371 |
0.40653 |
interleukin-6 receptor alpha subunit precursor (IL-6R-alpha; IL6R); CD126 antigen |
| 203 |
B01g |
0.10789 |
1.4204 |
0.15056 |
CDC7-related kinase |
| 583 |
C14i |
0.10792 |
0.85856 |
0.050663 |
jun activation domain binding protein |
| 892 |
E08j |
0.10817 |
1.3002 |
0.10769 |
endothelial plasminogen activator inhibitor-1 precursor (PAI1; PLANH1) |
| 994 |
F01n |
0.10853 |
0.64507 |
0.12755 |
septin 2 homolog; KIAA0128 |
| 176 |
A13h |
0.10989 |
1.3234 |
0.11708 |
active breakpoint cluster region-related protein |
| 735 |
D11g |
0.11037 |
0.78884 |
0.076647 |
envoplakin (EVPL) |
| 147 |
A11g |
0.11082 |
1.5286 |
0.19235 |
PIG7 |
| 472 |
C06j |
0.11097 |
0.80397 |
0.071386 |
PRB-binding protein E2F1; retinoblastoma-binding protein 3 (RBBP3); retinoblastoma-associated protein 1 (RBAP1); PBR3 |
| 680 |
D07h |
0.11106 |
0.70611 |
0.10707 |
CDW40 antigen; CD40L receptor precursor; nerve growth factor receptor-related B-lymphocyte activation molecule |
| 1127 |
F11g |
0.11248 |
0.78422 |
0.079217 |
restin; cytoplasmic linker protein 170 alpha ) (CLIP170); Reed-Sternberg intermediate filament-associated protein |
| 336 |
B10n |
0.11263 |
0.78632 |
0.078506 |
secreted apoptosis related protein 3 (SARP3) |
| 108 |
A08j |
0.11266 |
1.1489 |
0.054696 |
extracellular signal-regulated kinase 1 (ERK1; p44-ERK1); microtubule-associated protein 2 kinase; insulin-stimulated MAP2 kinase; MAP kinase 1 (MAPK1; p44-MAPK); PRKM3 |
| 952 |
E12n |
0.113 |
0.70599 |
0.10823 |
collagen 6 alpha 2 subunit (COL6A2) |
| 655 |
D05k |
0.11412 |
2.0062 |
0.3726 |
colon carcinoma kinase 4 precursor (CCK4) + transmembrane receptor PTK7 |
| 1182 |
G31 |
0.1147 |
0.58618 |
0.1537 |
HLA class I histocompatibility antigen C-4 alpha subunit (HLAC) |
| 354 |
B12d |
0.11568 |
1.2116 |
0.079012 |
focal adhesion kinase 2 (FADK2; FAK2); cell adhesion kinase beta (CAKbeta); proline-rich tyrosine kinase 2 (PYK2) |
| 717 |
D10c |
0.11671 |
1.2946 |
0.11056 |
T-cell surface glycoprotein CD8 beta.1 subunit precursor |
| 648 |
D05d |
0.11678 |
0.79728 |
0.076112 |
cadherin 8 (CDH8) |
| 273 |
B06g |
0.1176 |
1.1588 |
0.059869 |
protein tyrosine kinase |
| 73 |
A06c |
0.11771 |
1.3269 |
0.12332 |
N-myc proto-oncogene |
| 943 |
E12e |
0.11875 |
0.50812 |
0.18655 |
sonic hedgehog (SHH) |
| 363 |
B12m |
0.11888 |
0.72504 |
0.10434 |
guanylate kinase (GMP kinase) |
| 52 |
A04j |
0.11898 |
0.81639 |
0.069713 |
cell division protein kinase 4; cyclin-dependent kinase 4 (CDK4); PSK-J3 |
| 124 |
A09l |
0.1193 |
1.49 |
0.18634 |
cyclin-dependent kinase inhibitor 1 (CDKN1A); melanoma differentiation-associated protein 6 (MDA6); CDK-interacting protein 1 (CIP1); WAF1 |
| 335 |
B10m |
0.12029 |
0.57587 |
0.16211 |
junction plakoglobin (JUP); desmoplakin III (DP3) |
| 1051 |
F06a |
0.12121 |
0.63562 |
0.13992 |
laminin beta 2 subunit precursor (laminin B2; LAMB2); S-laminin |
| 788 |
E01d |
0.12138 |
0.6532 |
0.13328 |
ciliary neuronotrophic factor (CNTF) isoforms B & C |
| 53 |
A04k |
0.12209 |
1.116 |
0.044754 |
stem cell tyrosine kinase 1 (STK1); FL cytokine receptor precursor; tyrosine-protein kinase receptor flt3; CD135 antigen |
| 970 |
E14d |
0.12451 |
0.61377 |
0.15074 |
fibroblast growth factor 8 (FGF8); androgen-induced growth factor precursor (AIGF); HBGF8 |
| 944 |
E12f |
0.12518 |
0.63846 |
0.14157 |
interferon-beta (IFN-beta; IFNB); fibroblast interferon |
| 100 |
A08b |
0.12528 |
1.4731 |
0.18535 |
mothers against dpp homolog 4 (SMAD4); MADR4; pancreatic carcinoma gene 4 (DPC4) |
| 1175 |
F14m |
0.12611 |
0.58471 |
0.16336 |
clone PO2ST9 (brain striatum) |
| 101 |
A08c |
0.12615 |
1.4375 |
0.17211 |
MAD protein; MAX dimerizer |
| 423 |
C03c |
0.12691 |
1.1997 |
0.078849 |
bcl2 homologous antagonist/killer (BAK) |
| 11 |
A01k |
0.1272 |
1.5521 |
0.21832 |
wee1Hu CDK tyrosine 15-kinase; wee-1-like protein kinase |
| 872 |
E07d |
0.12758 |
0.63393 |
0.14502 |
vascular endothelial growth factor B precursor (VEGFB) + VEGF-related factor isoform VRF186 |
| 415 |
C02i |
0.12799 |
1.2559 |
0.10156 |
G/T mismatch-specific thymine DNA glycosylase (TDG) |
| 1148 |
F12n |
0.12852 |
0.64199 |
0.14247 |
clone 23815 (Soares library 1NIB from IMAGE Consortium) |
| 947 |
E12i |
0.12949 |
0.71387 |
0.11438 |
matrix metalloproteinase 14 precursor (MMP14); membrane-type matrix metalloproteinase 1 (MT-MMP1); MMP-X1 |
| 630 |
D03n |
0.13073 |
0.79469 |
0.082561 |
(2'-5')oligoadenylate synthetase 2 ((2-5')oligo(A) synthetase 2; 2-5A synthetase 2) |
| 132 |
A10f |
0.13368 |
1.2928 |
0.11936 |
matrix metalloproteinase 11 (MMP11); stromelysin 3 |
| 624 |
D03h |
0.134 |
1.4862 |
0.19853 |
guanine nucleotide-binding protein G(K) alpha 3 subunit (GNA3) |
| 897 |
E09a |
0.1344 |
0.84007 |
0.06542 |
bone morphogenetic protein 8 (BMP8; osteogenic protein 2 (OP2) |
| 172 |
A13d |
0.13714 |
1.4235 |
0.1754 |
ERBB2 receptor protein-tyrosine kinase; neu proto-oncogene; c-erbB2 + HER2 receptor |
| 1025 |
F04c |
0.13748 |
1.2183 |
0.090568 |
deoxycytidine kinase |
| 1137 |
F12c |
0.13752 |
0.76912 |
0.095793 |
bifunctional purine biosynthesis protein |
| 103 |
A08e |
0.13766 |
1.5371 |
0.223 |
C-src proto-oncogene (SRC1) |
| 765 |
D13i |
0.13793 |
0.78995 |
0.087316 |
70-80-kDa transforming growth factor beta receptor II |
| 377 |
B13m |
0.13853 |
0.73511 |
0.11041 |
GRB2-associated binder 1 (GAB1) |
| 184 |
A14b |
0.1389 |
2.2711 |
0.53068 |
c-fos proto-oncogene; G0S7 protein |
| 792 |
E01h |
0.13908 |
1.29 |
0.12119 |
ephrin-B2 precursor; EPH-related receptor tyrosine kinase ligand 5 (LERK-5); HTK ligand (HTK-L) |
| 958 |
E13f |
0.13977 |
0.5149 |
0.20333 |
interferon-alpha2 precursor (IFN-alpha; IFNA); leukocyte interferon-alphaA (LEIF A); roferon + IFN-alpha10 precursor; LEIF C; IFN-alpha-6L |
| 1083 |
F08e |
0.14013 |
0.79465 |
0.08621 |
adenylate kinase 3 (AK3); mitochondrial GTP:AMP phosphotransferase |
| 609 |
D02g |
0.14022 |
0.68367 |
0.13285 |
osteoblast specific factor 2 (OSF2); OSF-2P1 |
| 1149 |
F13a |
0.1405 |
1.1945 |
0.081798 |
versican core protein precursor; large fibroblast proteoglycan; chondroitin sulfate proteoglycan core protein 2; glial hyaluronate-binding protein (GHAP) |
| 7 |
A01g |
0.14063 |
1.7023 |
0.29549 |
5T4 oncofetal antigen precursor |
| 54 |
A04l |
0.14183 |
0.84438 |
0.065829 |
cell division protein kinase 8 (CDK8); protein kinase K35 |
| 745 |
D12c |
0.14207 |
0.70653 |
0.12427 |
T-cell surface glycoprotein CD5 precursor; lymphocyte glycoprotein T1/leu-1 |
| 941 |
E12c |
0.14231 |
0.76137 |
0.10116 |
delta-like protein precursor (DLK) |
| 984 |
F01d |
0.14276 |
0.78802 |
0.090038 |
xanthine dehydrogenase/oxidase |
| 865 |
E06k |
0.14363 |
1.5183 |
0.221 |
ubiquitin thiolesterase X-linked fat facets protein related (FAF-X); USP9; ubiquitin-specific processing protease; deubiquitinating enzyme; DFFRX + ubiquitin thiolesterase Y-linked fat facets protein related (FAF-Y); USP10; DFFRY |
| 466 |
C06d |
0.14372 |
0.87034 |
0.055302 |
sentrin; ubiquitin-like protein SMT3C; ubiquitin-homology domain protein PIC1; UBL1; SUMO-1; GAP modifying protein 1; GMP1 |
| 246 |
B04h |
0.14484 |
1.3905 |
0.16737 |
protein kinase DYRK2 |
| 154 |
A11n |
0.14867 |
0.81123 |
0.082255 |
regulator of chromosome condensation; cell cycle regulatory protein |
| 1106 |
F09n |
0.14963 |
0.59428 |
0.17751 |
mitogen-responsive phosphoprotein DOC2 |
| 1141 |
F12g |
0.15238 |
0.73177 |
0.11873 |
BCL7B protein |
| 287 |
B07g |
0.1527 |
1.0875 |
0.038787 |
skeletal muscle phosphorylase B kinase gamma catalytic subunit |
| 973 |
E14g |
0.1539 |
0.83153 |
0.075047 |
ephrin-B1 precursor; eph-related receptor tyrosine kinase ligand 2 (LERK-2); ELK ligand precursor (ELK-L) |
| 913 |
E10c |
0.1548 |
0.68443 |
0.1411 |
placenta growth factors 1 + 2 (PLGF1 + PLGF2 ) |
| 1 |
A01a |
0.15597 |
1.4602 |
0.20677 |
adenomatous polyposis coli protein (APC protein); DP2.5 |
| 210 |
B01n |
0.15607 |
0.73951 |
0.11709 |
CRK-like protein |
| 107 |
A08i |
0.15631 |
1.6279 |
0.28251 |
G1/S-specific cyclin D3 (CCND3) |
| 186 |
A14d |
0.15696 |
2.0644 |
0.48017 |
ERBB-3 receptor protein-tyrosine kinase precursor; epidermal growth factor receptor |
| 665 |
D06g |
0.1575 |
1.165 |
0.07461 |
cadherin 13 (CDH13); truncated cadherin precursor (T-cadherin); heart cadherin (H-cadherin) |
| 26 |
A02l |
0.1581 |
1.2688 |
0.12183 |
extracellular signal-regulated kinase 6 (ERK6); stress-activated protein kinase-3; mitogen-activated protein kinase p38 gamma; (MAP kinase p38 gamma) |
| 83 |
A06m |
0.15829 |
1.2543 |
0.11536 |
cell cycle progression 2 protein (CPR2) |
| 761 |
D13e |
0.15846 |
0.60265 |
0.18036 |
garp protein precursor; garpin |
| 555 |
C12i |
0.15856 |
0.58194 |
0.18984 |
TIS11B protein; EGF response factor 1 (ERF1) |
| 1059 |
F06i |
0.1587 |
1.8096 |
0.36785 |
protein P84 |
| 549 |
C12c |
0.15973 |
0.71988 |
0.1278 |
rac-alpha serine/threonine kinase (rac-PK-alpha); protein kinase B (PKB); c-akt; akt1 |
| 155 |
A12a |
0.15979 |
1.3426 |
0.15637 |
putative protein-tyrosine phosphatase PTEN; mutated in multiple advanced cancers 1 |
| 6 |
A01f |
0.15993 |
1.6199 |
0.28305 |
transforming protein p21/K-ras 2B |
| 451 |
C05c |
0.16513 |
1.239 |
0.11141 |
apoptosis regulator bcl-2 |
| 997 |
F02c |
0.16564 |
0.85051 |
0.069837 |
methylenetetrahydrofolate dehydrogenase- methylenetetrahydrofolate cyclohydrolase-formyltetrahydrofolate synthetase |
| 1161 |
F13m |
0.16579 |
0.64347 |
0.16665 |
P18 protein |
| 114 |
A09b |
0.16631 |
1.77 |
0.36064 |
c-myc purine-binding transcription factor puf; nucleoside diphosphate kinase B (NDP kinase B; NDKB) + nm23-H2S |
| 482 |
C07f |
0.16709 |
0.81449 |
0.087157 |
DNA primase small subunit; DNA primase 49-kDa subunit |
| 670 |
D06l |
0.16745 |
1.2229 |
0.10486 |
ephrin type-A receptor 5 precursor; tyrosine-protein kinase receptor EHK1; EPH homology kinase-1; HEK7 |
| 519 |
C10a |
0.16794 |
1.4702 |
0.22163 |
tumor necrosis factor receptor 1-associated death domain protein (TNFR1-associated death domain protein; TRADD) |
| 216 |
B02f |
0.16797 |
1.1628 |
0.076749 |
KIAA0135 |
| 1060 |
F06j |
0.16834 |
1.5174 |
0.24425 |
phosphatidic acid phosphatase 2B |
| 1058 |
F06h |
0.16838 |
2.4026 |
0.66232 |
interferon-regulated resistance GTP-binding protein MXAB |
| 1046 |
F05j |
0.16839 |
1.6066 |
0.28646 |
"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase; beta-galactoside alpha-2,6-sialyltransferase (alpha-2,6-ST); sialyltransferase 1 (SIAT1); B-cell CD75 antigen" |
| 1084 |
F08f |
0.16994 |
0.63533 |
0.17324 |
type I cytoskeletal 18 keratin; cytokeratin 18 (K18) |
| 28 |
A02n |
0.17144 |
1.1778 |
0.08495 |
growth inhibitory factor; metallothionein-III (MT-III) |
| 838 |
E04l |
0.17147 |
0.85253 |
0.070476 |
major histocompatibility complex encoded proteasome subunit LMP2 |
| 398 |
C01f |
0.17255 |
0.65245 |
0.16678 |
activator 1 40-kDa subunit; replication factor C 40-kDa subunit (RFC40); RFC2 |
| 966 |
E13n |
0.173 |
1.1728 |
0.08306 |
collagen 6 alpha 3 subunit (COL6A3) |
| 786 |
E01b |
0.17463 |
0.71562 |
0.13756 |
kidney epidermal growth factor (EGF); urogastrone |
| 473 |
C06k |
0.17522 |
0.84134 |
0.076917 |
interferon regulatory factor 1 (IRF1) |
| 880 |
E07l |
0.17526 |
1.3499 |
0.16967 |
ubiquitin-activating enzyme E1-related protein |
| 128 |
A10b |
0.17534 |
1.3199 |
0.15514 |
nucleoside diphosphate kinase A (NDKA); NDP kinase A; tumor metastatic process-associated protein; metastasis inhibition factor NM23 (NM23-H1) |
| 729 |
D11a |
0.17594 |
0.76258 |
0.11541 |
heterochromatin protein homolog 1 (HP1) |
| 384 |
B14f |
0.17648 |
1.3676 |
0.17905 |
mitogen-activated protein kinase kinase kinase (MAP kinase kinase kinase; MTK1) |
| 696 |
D08j |
0.17657 |
0.8303 |
0.082688 |
interferon-gamma (IFN-gamma) receptor beta subunit precursor; IFN-gamma accessory factor 1 (AF1); IFN-gamma transducer 1 (IFNGT1) |
| 552 |
C12f |
0.17724 |
0.75843 |
0.118 |
ataxia telangiectasia (ATM) |
| 704 |
D09d |
0.17937 |
1.1996 |
0.098295 |
alpha1 catenin (CTNNA1); cadherin-associated protein; alpha E-catenin |
| 1184 |
G45 |
0.17941 |
0.6956 |
0.14991 |
23-kDa highly basic protein; 60S ribosomal protein L13A (RPL13A) |
| 572 |
C13l |
0.17965 |
0.76893 |
0.1139 |
muscarinic acetylcholine receptor M4 (CHRM4) |
| 589 |
D01a |
0.18351 |
1.1921 |
0.096076 |
guanine nucleotide-binding protein G(I) alpha 1 subunit (GNAI1); adenylate cyclase-inhibiting G alpha protein |
| 233 |
B03i |
0.18448 |
1.2975 |
0.14929 |
protein tyrosine phosphatase sigma |
| 686 |
D07n |
0.18603 |
0.77225 |
0.11493 |
neurotrophin-3 precursor (NT-3); neurotrophic factor (HDNF); nerve growth factor 2 (NGF-2) |
| 946 |
E12h |
0.18671 |
0.63738 |
0.18345 |
Wnt-2; int-1 related protein (IRP) |
| 1151 |
F13c |
0.18816 |
0.71558 |
0.14465 |
adenine phosphoribosyltransferase (APRT) |
| 538 |
C11f |
0.18834 |
0.76805 |
0.11803 |
DNA topoisomerase III (TOP3) |
| 187 |
A14e |
0.18834 |
1.8518 |
0.43347 |
H-ras proto-oncogene; transforming G protein |
| 364 |
B12n |
0.18879 |
0.7043 |
0.15072 |
insulin-like growth factor I receptor (IGF1R) |
| 1145 |
F12k |
0.19115 |
0.74373 |
0.13173 |
fau |
| 446 |
C04l |
0.19166 |
0.7049 |
0.15197 |
retinoic acid receptor alpha; retinoid X receptor alpha (RXRA) |
| 666 |
D06h |
0.19193 |
0.76298 |
0.12218 |
keratinocyte growth factor receptor (KGFR); fibroblast growth factor receptor 2 (FGFR2) + soluble KGFR + FGF-BEK; heparin-binding growth factor receptor K-sam (HGFR K-sam) + secreted FGFR K-sam-III + secreted FGFR K-sam-IV |
| 277 |
B06k |
0.19276 |
1.2248 |
0.1162 |
rho GDP dissociation inihibitor 2 (RHO GDI2; RHO-GDI beta); LY-GDI; ARHGDIB; GDID4 |
| 718 |
D10d |
0.19358 |
1.6094 |
0.31599 |
neural-cadherin precursor (N-cadherin; NCAD); cadherin 2 (CDH2) |
| 933 |
E11i |
0.19508 |
0.78736 |
0.11084 |
matrix metalloproteinase 12 (MMP12); metalloelastase |
| 71 |
A06a |
0.19526 |
1.2401 |
0.12523 |
moesin-ezrin-radixin-like protein (MERLIN); schwannomin (SCH); neurofibromatosis 2 (NF2) |
| 675 |
D07c |
0.19534 |
1.3881 |
0.20249 |
RAGE-4 ORF3 |
| 1136 |
F12b |
0.196 |
1.1727 |
0.090327 |
dopachrome tautomerase; dopachrome delta-isomerase |
| 927 |
E11c |
0.19692 |
0.68915 |
0.16309 |
insulin-like growth factor IA precursor (IGF1A); IGFBP1; somatomedin C + insulin-like growth factor I (IGF1) |
| 926 |
E11b |
0.19728 |
1.5819 |
0.30569 |
stem cell factor precursor (SCF); mast cell growth factor (MGF); c-kit ligand |
| 883 |
E08a |
0.19782 |
0.61907 |
0.20049 |
bone morphogenetic protein 6 precursor (BMP6) |
| 72 |
A06b |
0.19828 |
1.2111 |
0.11129 |
prohibitin (PHB) |
| 1024 |
F04b |
0.19869 |
0.70936 |
0.15344 |
heparan sulfate proteoglycan (HSPG2) |
| 59 |
A05c |
0.19954 |
1.568 |
0.30076 |
L-myc proto-oncogene (MYCL1) |
| 640 |
D04j |
0.19967 |
1.5197 |
0.2753 |
interferon-alpha/beta receptor alpha subunit precursor (IFN-alpha receptor; IFNAR) |
| 388 |
B14j |
0.20022 |
1.2454 |
0.13026 |
rho GDP dissociation inihibitor 1 (RHO-GDI 1); RHO-GDI alpha (GDIA1); ARHGDIA |
| 1074 |
F07j |
0.20106 |
1.3336 |
0.17756 |
probable protein disulfide isomerase ER-60 precursor (ERP60); 58-kDa microsomal protein; phospholipase C alpha |
| 418 |
C02l |
0.20236 |
0.75358 |
0.13176 |
p73 (monoallelically expressed p53-related protein) |
| 9 |
A01i |
0.20241 |
1.3796 |
0.20299 |
leukemia-associated gene 1 |
| 502 |
C08l |
0.20252 |
0.80433 |
0.10467 |
retinoic acid receptor alpha 1 (RAR-alpha 1; RARA) + PML-RAR protein |
| 1023 |
F04a |
0.20283 |
0.70856 |
0.15608 |
collagen 18 alpha 1 subunit (COL18A1) |
| 898 |
E09b |
0.20496 |
0.63439 |
0.19723 |
vascular endothelial growth factor precursor (VEGF); vascular permeability factor (VPF) |
| 247 |
B04i |
0.20721 |
0.9066 |
0.050776 |
phosphotyrosyl phosphatase activator |
| 968 |
E14b |
0.20826 |
0.61258 |
0.21136 |
keratinocyte growth factor (KGF); fibroblast growth factor 7 (FGF7) |
| 153 |
A11m |
0.20879 |
1.4618 |
0.25241 |
CDC16HS |
| 916 |
E10f |
0.209 |
0.63528 |
0.19947 |
interleukin-6 precursor (IL-6); B-cell stimulatory factor 2 (BSF2); interferon beta-2 (IFNB2); hybridoma growth factor |
| 156 |
A12b |
0.20907 |
1.4564 |
0.24969 |
LUCA15 putative tumor suppressor |
| 85 |
A07a |
0.20986 |
1.2061 |
0.11304 |
retinoblastoma-like protein 2 (RBL2; RB2); 130-kDa retinoblastoma-associated protein |
| 389 |
B14k |
0.20992 |
0.80374 |
0.10767 |
51C protein (homology with inositol polyphosphate phosphatases) |
| 302 |
B08h |
0.21097 |
1.3102 |
0.17076 |
PTPCAAX1 nuclear tyrosine phosphatase (PRL-1) |
| 737 |
D11i |
0.21121 |
1.2383 |
0.13132 |
bone morphogenetic protein 4 type II receptor precursor (BMPR II) |
| 1082 |
F08d |
0.21178 |
0.64618 |
0.19533 |
multifunctional protein ADE2 |
| 937 |
E11m |
0.21179 |
1.6976 |
0.38512 |
MHC class I molecule + MHC class I subunit-related protein A (MICA); PERB11.1 |
| 772 |
D14b |
0.21258 |
0.72917 |
0.14992 |
T-cell surface glycoprotein E2 precursor; CD99 antigen; MIC2 protein |
| 497 |
C08g |
0.21492 |
0.52986 |
0.26228 |
mutL protein homolog; DNA mismatch repair protein MLH1; COCA2 |
| 1089 |
F08k |
0.21523 |
0.77628 |
0.12494 |
eukaryotic translation initiation factor 3 beta subunit (EIF-3 beta); EIF3 P116 |
| 1033 |
F04k |
0.21557 |
0.77953 |
0.12326 |
60S ribosomal protein L5 |
| 900 |
E09d |
0.21572 |
0.71792 |
0.15778 |
B-cell growth factor 1 precursor (BCGF1); 12-kDa BCGF |
| 1056 |
F06f |
0.21616 |
4.941 |
2.2076 |
type I cytoskeletal 14 keratin; cytokeratin 14 (K14; CK14) |
| 565 |
C13e |
0.21665 |
0.90876 |
0.051195 |
proliferating cyclic nuclear antigen (PCNA); cyclin |
| 606 |
D02d |
0.21672 |
0.67664 |
0.18148 |
cadherin 5 (CDH5); vascular endothelial cadherin precursor (VE-cadherin); 7B4 antigen; CD144 antigen |
| 891 |
E08i |
0.21758 |
1.2438 |
0.13724 |
matrix metalloproteinase 7 (MMP7); matrilysin |
| 922 |
E10l |
0.21789 |
1.6308 |
0.35537 |
TAPASIN |
| 846 |
E05f |
0.21818 |
0.60287 |
0.22395 |
interleukin-2 precursor (IL-2); T-cell growth factor (TCGF) |
| 949 |
E12k |
0.21853 |
2.0157 |
0.57342 |
urokinase-type plasminogen activator precursor (U-plasminogen activator; UPA) |
| 487 |
C07k |
0.21892 |
1.0607 |
0.03432 |
NF-kappaB transcription factor p65 subunit; RELA; NFKB3 |
| 1123 |
F11c |
0.21913 |
0.75434 |
0.13896 |
uridine diphosphoglucose pyrophosphorylase; UTP-glucose-1-phosphate uridylyltransferase |
| 798 |
E01n |
0.21929 |
0.702 |
0.16866 |
unrearranged immunoglobulin V(H)5 pseudogene |
| 1119 |
F10m |
0.22125 |
0.58536 |
0.23619 |
interferon alpha-induced 11.5-kDa protein |
| 557 |
C12k |
0.22277 |
0.82757 |
0.098707 |
FHF-1 |
| 274 |
B06h |
0.2231 |
0.75491 |
0.14045 |
leukocyte antigen-related protein precursor (LAR) ; PTPRF + leukocyte surface CD47 antigen precursor; antigenic surface determinant protein OA3; integrin-associated protein (IAP) |
| 1098 |
F09f |
0.2233 |
1.3258 |
0.18685 |
type I cytoskeletal 19 keratin; cytokeratin 19 (K19; CK19) |
| 357 |
B12g |
0.22355 |
1.2375 |
0.13628 |
phosphorylase B kinase beta regulatory subunit |
| 830 |
E04d |
0.22375 |
0.69753 |
0.1737 |
erythropoietin |
| 1030 |
F04h |
0.22518 |
0.85874 |
0.081495 |
regulator of G protein signaling 4 (RGS4; RGP4) |
| 938 |
E11n |
0.2264 |
1.0821 |
0.047556 |
collagen 6 alpha 1 subunit (COL6A1) |
| 1066 |
F07b |
0.22752 |
0.82652 |
0.10084 |
Golgi alpha-mannosidase II |
| 50 |
A04h |
0.22759 |
1.2465 |
0.14332 |
neurogenic locus notch protein homolog 1 precursor (NOTCH1); translocation-associated notch protein (TAN1) |
| 171 |
A13c |
0.22976 |
1.1487 |
0.087066 |
fos-related antigen (FRA1) |
| 875 |
E07g |
0.23234 |
0.61755 |
0.22576 |
interleukin-9 precursor (IL-9); T-cell growth factor p40 |
| 74 |
A06d |
0.23325 |
1.135 |
0.079935 |
cot proto-oncogene |
| 1042 |
F05f |
0.23356 |
2.0438 |
0.61854 |
type I cytoskeletal 13 keratin; cytokeratin 13 (K13; CK13) + type I cytoskeletal 15 keratin; cytokeratin 15 (K15; CK15) + type I cytoskeletal 17 keratin; cytokeratin 17 (K17; CK17) |
| 386 |
B14h |
0.23361 |
1.9928 |
0.58844 |
KIAA0283 |
| 492 |
C08b |
0.23498 |
0.81296 |
0.11134 |
caspase-4 precursor (CASP4); ICH-2 protease; TX protease; ICE(REL)-II + caspase-5 precursor (CASP5); ICH-3 protease; TY protease; ICE(REL)-III |
| 516 |
C09l |
0.23558 |
0.72915 |
0.16153 |
transcription factor E2F5 |
| 576 |
C14b |
0.23728 |
0.65395 |
0.20749 |
caspase-7 precursor (CASP7); ICE-like apoptotic protease 3 (ICE-LAP3); apoptotic protease MCH-3; CMH-1 |
| 541 |
C11i |
0.23736 |
0.88987 |
0.06605 |
cyclic-AMP-dependent transcription factor atr-1; TREB36 protein |
| 320 |
B09l |
0.23881 |
0.70524 |
0.17757 |
58-kDa inhibitor of the RNA-activated protein kinase |
| 595 |
D01g |
0.24158 |
1.4034 |
0.24511 |
neural cell adhesion molecule; CALL |
| 355 |
B12e |
0.24216 |
1.1371 |
0.083492 |
serine/threonine-protein kinase PCTAIRE 2 (PCTK2) |
| 444 |
C04j |
0.24342 |
0.82025 |
0.10985 |
BRCA1-associated ring domain protein |
| 286 |
B07f |
0.2448 |
1.7104 |
0.43601 |
trio |
| 975 |
E14i |
0.24499 |
0.84243 |
0.096766 |
matrix metalloproteinase 16 precursor (MMP16); membrane-type matrix metalloproteinase 3 (MT-MMP3); MMP-X2 |
| 669 |
D06k |
0.24557 |
0.72429 |
0.16962 |
tyrosine kinase receptor tie-1 precursor |
| 749 |
D12g |
0.24643 |
1.3394 |
0.20934 |
desmoglein 1 precursor (DSG1); desmosomal glycoprotein 1 (DG1) |
| 351 |
B12a |
0.24892 |
1.347 |
0.2157 |
growth factor receptor-bound protein 2 (GRB2) isoform; GRB3-3; SH2/SH3 adaptor GRB2; ASH protein + epidermal growth factor receptor-bound protein 2 (EGFRBP-GRB2) |
| 571 |
C13k |
0.24942 |
2.7435 |
1.0854 |
interferon regulatory factor 6 (IRF6) |
| 1183 |
G43 |
0.25008 |
0.6437 |
0.22224 |
cytoplasmic beta-actin (ACTB) |
| 316 |
B09h |
0.25091 |
1.4246 |
0.26551 |
protein phosphatase 2A B56-alpha |
| 1017 |
F03i |
0.25139 |
0.8807 |
0.074715 |
hemoglobin alpha subunit |
| 918 |
E10h |
0.25213 |
0.6321 |
0.23092 |
manic fringe |
| 409 |
C02c |
0.25224 |
1.4425 |
0.27784 |
BCL-2 binding athanogene-1 (BAG-1); glucocorticoid receptor-associated protein RAP46 |
| 848 |
E05h |
0.25268 |
1.0979 |
0.061533 |
beta-adrenergic receptor kinase 1 (beta-ARK1; BARK1; ADRBK1); G protein-coupled receptor kinase 2 (GRK2) |
| 1070 |
F07f |
0.25337 |
2.2488 |
0.78681 |
type I cytoskeletal 16 keratin; cytokeratin 16 (K16; CK16); pseudo-keratin K16 type I |
| 804 |
E02f |
0.25381 |
0.84778 |
0.096031 |
insulin-like growth factor-binding protein 3 precursor (IGF-binding protein 3; IGFBP3; IBP3) |
| 104 |
A08f |
0.25384 |
1.2065 |
0.13026 |
insulin-like growth factor binding protein 2 (IGFBP2) |
| 125 |
A09m |
0.25447 |
1.1072 |
0.067758 |
p53-dependent cell growth regulator CGR19 |
| 10 |
A01j |
0.25482 |
2.0894 |
0.68937 |
cyclin I |
| 1115 |
F10i |
0.25662 |
0.62384 |
0.23932 |
arginine/serine-rich splicing factor 7; splicing factor 9G8 |
| 63 |
A05g |
0.25721 |
1.367 |
0.23392 |
gamma-interferon-inducible protein; IP-30 |
| 206 |
B01j |
0.25738 |
1.1428 |
0.091083 |
GTP-binding protein ras associated with diabetes (RAD1) |
| 32 |
A03d |
0.25836 |
1.2726 |
0.17434 |
B-raf proto-oncogene (RAFB1) |
| 650 |
D05f |
0.25945 |
1.4105 |
0.26338 |
integrin alpha 9 (ITGA9); integrin alpha-RLC |
| 453 |
C05e |
0.26083 |
1.4582 |
0.29521 |
P53-BINDING PROTEIN 53BP1 |
| 725 |
D10k |
0.26112 |
1.5993 |
0.38644 |
lymphotoxin beta receptor precursor; tumor necrosis factor receptor 2-related protein; tumor necrosis factor C receptor |
| 1028 |
F04f |
0.26235 |
1.421 |
0.27247 |
type I cytoskeletal 12 keratin; cytokeratin 12 (K12) |
| 352 |
B12b |
0.26284 |
1.284 |
0.1841 |
JV18-1. HMAD-2 OR MADR2 OR SMAD2 |
| 212 |
B02b |
0.26293 |
1.4088 |
0.26507 |
NCK melanoma cytoplasmic src homolog (HSNCK) |
| 209 |
B01m |
0.2654 |
0.64748 |
0.23023 |
linker for activation of T-cells (LAT) |
| 467 |
C06e |
0.26563 |
1.4599 |
0.30055 |
CC3 (CC3) |
| 784 |
D14n |
0.26622 |
0.69016 |
0.20285 |
semaphorin |
| 181 |
A13m |
0.26743 |
0.71374 |
0.18808 |
retinoblastoma-binding protein 1 (RBP1) isoform I + isoform II |
| 1165 |
F14c |
0.26765 |
0.76244 |
0.15618 |
adenylosuccinate lyase; adenylosuccinase (ASL) |
| 405 |
C01m |
0.26814 |
0.8266 |
0.11417 |
zinc finger protein 22; KOX15 |
| 980 |
E14n |
0.26817 |
0.73511 |
0.17442 |
collagen 8 alpha 1 subunit (COL8A1) |
| 70 |
A05n |
0.26948 |
0.91637 |
0.055283 |
CDC37 homolog |
| 769 |
D13m |
0.27015 |
1.3354 |
0.22213 |
tyrosinase precursor; monophenol monooxygenase |
| 257 |
B05e |
0.27063 |
0.91347 |
0.057389 |
STE20-like kinase 3; MST3 |
| 885 |
E08c |
0.27112 |
0.72873 |
0.18017 |
platelet-derived growth factor A subunit precursor (PDGFA; PDGF1) |
| 1093 |
F09a |
0.27222 |
0.78403 |
0.14391 |
netrin-2 |
| 1020 |
F03l |
0.27226 |
0.67508 |
0.21653 |
KIAA0303 |
| 1018 |
F03j |
0.2733 |
1.2495 |
0.16679 |
80-kDa nuclear cap-binding protein |
| 974 |
E14h |
0.27428 |
0.74218 |
0.17283 |
Wnt-8B |
| 223 |
B02m |
0.27494 |
1.2125 |
0.14269 |
hint protein; protein kinase C inhibitor 1 (PKCI1) |
| 582 |
C14h |
0.27496 |
0.76321 |
0.15904 |
damage-specific DNA binding protein p48 subunit (DDBB P48); implicated in xeroderma pigmentosum group E (DDB2) |
| 568 |
C13h |
0.27594 |
1.0723 |
0.048688 |
ALKB homolog protein |
| 138 |
A10l |
0.27622 |
1.1379 |
0.092961 |
cell division cycle protein 25A (CDC25A); M-phase inducer phosphatase 1 |
| 498 |
C08h |
0.27642 |
0.78422 |
0.14555 |
DNA mismatch repair protein MSH2 |
| 629 |
D03m |
0.27655 |
1.6134 |
0.41393 |
low-density lipoprotein receptor-related protein 1 precursor (LRP); alpha-2-macroglobulin receptor (A2MR); apolipoprotein E receptor (APOER); CD91 antigen |
| 1179 |
G15 |
0.27711 |
0.81435 |
0.12548 |
hypoxanthine-guanine phosphoribosyltransferase (HPRT) |
| 893 |
E08k |
0.27822 |
1.331 |
0.22444 |
bikunin; hepatocyte growth factor activator inhibitor 2 |
| 18 |
A02d |
0.27875 |
1.2982 |
0.20251 |
A-raf proto-oncogene serine/threonine-protein kinase; PKS2 |
| 236 |
B03l |
0.27895 |
0.8392 |
0.10926 |
"cAMP-dependent 3',5'-cyclic phosphodiesterase 4B (DPDE4); PDE32" |
| 837 |
E04k |
0.27897 |
1.2566 |
0.17435 |
PRSM1 metallopeptidase |
| 345 |
B11i |
0.27925 |
0.68869 |
0.21171 |
transforming protein rhoB; ARHB; ARH6 |
| 964 |
E13l |
0.27943 |
2.315 |
0.89475 |
HLA class II histocompatibility antigen alpha chain precursor |
| 822 |
E03j |
0.27952 |
1.1724 |
0.11732 |
cathepsin D precursor (CTSD) |
| 955 |
E13c |
0.28016 |
0.71252 |
0.19602 |
monocyte chemotactic protein 4 precursor (MCP4); monocyte chemoattractant protein 4; CK-beta10; NCC-1 |
| 1005 |
F02k |
0.28076 |
0.85268 |
0.10062 |
40S ribosomal protein S5 |
| 981 |
F01a |
0.28133 |
0.6772 |
0.22085 |
collagen 11 alpha 1 subunit precursor (COL11A1) |
| 646 |
D05b |
0.28197 |
0.89954 |
0.068859 |
DNA-binding protein RFX5 |
| 450 |
C05b |
0.28353 |
0.74192 |
0.17769 |
death-associated protein 1 (DAP1) |
| 22 |
A02h |
0.28366 |
1.4507 |
0.31043 |
p53-induced protein |
| 912 |
E10b |
0.28391 |
0.81581 |
0.12696 |
pleiotrophin precursor (PTN) + osteoblast specific factor 1 (OSF-1) + heparin-binding neurite outgrowth promoting factor 1 (HBNF-1) ; heparin-binding growth-associated molecule (HB-GAM); heparin-binding growth factor 8 (HBGF-8) |
| 615 |
D02m |
0.28514 |
2.0464 |
0.72381 |
KIAA0407 |
| 75 |
A06e |
0.28538 |
1.2662 |
0.18428 |
proto-oncogene tyrosine-protein kinase abl; p150; c-abl |
| 524 |
C10f |
0.28642 |
1.4536 |
0.31492 |
DNA nucleotidylexotransferase; terminal addition enzyme; terminal deoxynucleotidyltransferase (TDT); terminal transferase; DNTT |
| 1156 |
F13h |
0.28681 |
0.68382 |
0.21974 |
importin beta 1 subunit; karyopherin beta 1 subunit; importin 90; nuclear factor p97 |
| 871 |
E07c |
0.28802 |
0.67688 |
0.22534 |
interferon gamma-induced protein precursor (gamma-IP10) |
| 1041 |
F05e |
0.28986 |
1.0521 |
0.036524 |
ornithine decarboxylase |
| 954 |
E13b |
0.29067 |
0.76554 |
0.16475 |
hepatocyte growth factor (HGF); scatter factor (SF); hepatopoeitin A |
| 387 |
B14i |
0.29074 |
1.6694 |
0.47047 |
vav oncogene |
| 20 |
A02f |
0.29129 |
1.4555 |
0.32066 |
N-ras; transforming p21 protein |
| 801 |
E02c |
0.29171 |
0.70456 |
0.2082 |
endothelin 2 (ET2) |
| 500 |
C08j |
0.2928 |
0.88746 |
0.079556 |
nuclear factor NF-kappa-B p100 subunit; nuclear factor NF-kappa-B p52 subunit; H2TF1; oncogene lyt-10 |
| 1120 |
F10n |
0.29316 |
0.56336 |
0.30898 |
zygini; FEZ1-T |
| 229 |
B03e |
0.29326 |
1.1894 |
0.13404 |
PKU-alpha |
| 977 |
E14k |
0.29365 |
2.8957 |
1.3433 |
hepatocyte growth factor-like protein (HGF activator-like protein); hyaluronan-binding protein (PHBP) |
| 965 |
E13m |
0.29445 |
1.5768 |
0.40968 |
immunoglobulin alpha 1 heavy chain constant region (IgA1; IGHA1) + immunoglobulin alpha 2 heavy chain constant region (IgA2; IGHA2) |
| 477 |
C07a |
0.29478 |
1.4998 |
0.35534 |
cytotoxic ligand TRAIL receptor |
| 113 |
A09a |
0.29538 |
1.3094 |
0.22032 |
retinoblastoma-associated protein (RB1); PP110; P105-RB |
| 197 |
B01a |
0.29551 |
1.2703 |
0.19253 |
high-affinity glutamate transporter; excitatory amino acid transporter 3; sodium-dependent glutamate/aspartate transporter 3; excitatory amino acid carrier 1 (EAAC1) |
| 201 |
B01e |
0.29723 |
1.4695 |
0.3361 |
ribosomal protein S6 kinase II alpha 3 (S6KII-alpha 3); ribosomal S6 kinase 2 (RSK2); insulin-stimulated protein kinase 1 (ISPK1) |
| 318 |
B09j |
0.29877 |
0.81039 |
0.13632 |
rho-related GTP-binding protein (RHOG); ARHG |
| 44 |
A04b |
0.29915 |
1.4887 |
0.35168 |
transforming growth factor-beta 3 (TGF-beta3) |
| 1065 |
F07a |
0.29943 |
0.7443 |
0.18417 |
laminin beta 1 subunit precursor (laminin B1; LAMB1) |
| 688 |
D08b |
0.29976 |
0.72371 |
0.19918 |
histone H4 |
| 751 |
D12i |
0.29991 |
1.1518 |
0.10951 |
fibroblast growth factor receptor 4 (FGFR4) |
| 340 |
B11d |
0.30096 |
1.1259 |
0.091039 |
cAMP-dependent protein kinase gamma-catalytic subunit (PKA C-gamma) |
| 116 |
A09d |
0.30127 |
0.72737 |
0.19737 |
c-kit proto-oncogene; mast/stem cell growth factor receptor precursor (SCFR); CD117 antigen |
| 129 |
A10c |
0.30144 |
1.1974 |
0.14295 |
elk-1; ets-related proto-oncogene |
| 91 |
A07g |
0.30213 |
1.2179 |
0.15815 |
matrix metalloproteinase 18 (MMP18) + MMP19 |
| 90 |
A07f |
0.30257 |
1.5987 |
0.43498 |
cell surface glycoprotein MUC18; melanoma-associated antigen A32; CD146 antigen; melanoma adhesion molecule |
| 533 |
C11a |
0.30305 |
1.4868 |
0.35416 |
caspase & rip adaptator with death domain (CRADD); rip-associated protein with death domain (RAIDD) |
| 397 |
C01e |
0.3032 |
1.8679 |
0.6317 |
seven in absentia homolog |
| 581 |
C14g |
0.30389 |
1.2686 |
0.19591 |
DNA-repair protein complementing XP-C cells; xeroderma pigmentosum group C complementing protein (p125) |
| 462 |
C05n |
0.30456 |
0.85033 |
0.10935 |
zinc finger protein |
| 935 |
E11k |
0.30507 |
1.7013 |
0.51314 |
bleomycin hydrolase (BLM hydrolase) |
| 360 |
B12j |
0.30564 |
0.73871 |
0.19148 |
ras-related C3 botulinum toxin substrate 2; p21-rac2; small G protein |
| 657 |
D05m |
0.30724 |
2.0521 |
0.77448 |
purinergic receptor P2Y5 |
| 621 |
D03e |
0.30735 |
0.81585 |
0.13559 |
integrin alpha 3 (ITGA3); galactoprotein B3 (GAPB3); VLA3 alpha subunit; CD49C antigen |
| 768 |
D13l |
0.30915 |
1.3229 |
0.23891 |
frizzled 5 |
| 259 |
B05g |
0.30945 |
0.84145 |
0.11742 |
serine/threonine protein kinase minibrain homolog; HP86; DYRK |
| 1080 |
F08b |
0.30976 |
0.77031 |
0.17026 |
UMK |
| 48 |
A04f |
0.31033 |
1.3447 |
0.25589 |
platelet-derived growth factor B subunit precursor (PDGFB; PDGF2); bacaplermin; c-sis |
| 716 |
D10b |
0.31103 |
1.2616 |
0.19462 |
nuclear autoantigen spreckled 100-kDa (SP100) |
| 1031 |
F04i |
0.31201 |
1.1858 |
0.13859 |
neutrophil gelatinase-associated lipocalin precursor (NGAL); 25-kDa alpha-2-microglobulin-related subunit of MMP9); lipocalin 2; oncogene 24P3 |
| 31 |
A03c |
0.31213 |
0.88009 |
0.089465 |
c-myc oncogene |
| 96 |
A07l |
0.31288 |
1.5315 |
0.3974 |
cyclin-dependent kinase 4 inhibitor D (CDKN2D); p19-INK4D |
| 362 |
B12l |
0.31419 |
1.4463 |
0.33488 |
STAT-induced STAT inhibitor 3 |
| 671 |
D06m |
0.3156 |
1.4665 |
0.35139 |
cytosolic superoxide dismutase 1 (SOD1) |
| 330 |
B10h |
0.3166 |
1.2433 |
0.1838 |
protein phosphatase 2A B56-beta (PP2A) |
| 219 |
B02i |
0.31709 |
0.88255 |
0.088842 |
protein phosphatase 2C gamma |
| 3 |
A01c |
0.31912 |
1.5689 |
0.43271 |
c-jun proto-oncogene; transcription factor AP-1 |
| 1174 |
F14l |
0.3192 |
0.66706 |
0.2533 |
adducin gamma subunit |
| 244 |
B04f |
0.31931 |
1.2568 |
0.19543 |
STE20-like kinase; MST2 |
| 29 |
A03a |
0.32062 |
1.2707 |
0.20673 |
tumor suppressor protein DCC precursor; colorectal cancer suppressor |
| 221 |
B02k |
0.32083 |
0.89746 |
0.078363 |
regulator of G protein signaling 14 (RGS14) |
| 815 |
E03c |
0.32198 |
0.63871 |
0.27696 |
hepatocyte growth factor-like protein; macrophage-stimulating protein (MSP) |
| 661 |
D06c |
0.32238 |
1.2474 |
0.18989 |
mesothelin precursor; CAK1 antigen |
| 787 |
E01c |
0.32371 |
0.88824 |
0.086082 |
brain-derived neurotrophic factor (BDNF) |
| 276 |
B06j |
0.32415 |
1.432 |
0.33316 |
Rho7 protein |
| 759 |
D13c |
0.32472 |
0.75495 |
0.18926 |
lymphoid-restricted membrane protein |
| 127 |
A10a |
0.32476 |
1.2708 |
0.20918 |
Von Hippel-Lindau tumor suppressor protein (VHL) |
| 752 |
D12j |
0.32558 |
0.72266 |
0.2147 |
IL-1RRP precursor |
| 317 |
B09i |
0.326 |
0.81557 |
0.14294 |
protein tyrosine phosphatase sigma |
| 545 |
C11m |
0.32687 |
1.4118 |
0.31989 |
putative regulatory protein TGF-beta-stimulated clone 22 homolog (TSC22) |
| 618 |
D03b |
0.32796 |
1.9262 |
0.72169 |
DNA-binding protein CPBP |
| 5 |
A01e |
0.32799 |
1.2993 |
0.23319 |
ERBB4 receptor protein-tyrosine kinase; Her4 tyrosine kinase-EGF receptor related |
| 443 |
C04i |
0.32822 |
0.91277 |
0.06801 |
endonuclease III homolog 1 (HNTH1) (OCTS3) |
| 40 |
A03l |
0.32844 |
1.4912 |
0.38325 |
checkpoint kinase 1 (CHK1) |
| 950 |
E12l |
0.3286 |
1.8682 |
0.6776 |
T cell receptor variable region |
| 878 |
E07j |
0.32935 |
1.0764 |
0.059762 |
protein C inhibitor (PROCI; PCI); plasma serine protease inhibitor precursor; plasminogen activator inhibitor 3 (PLANH3; PAI3) |
| 829 |
E04c |
0.33097 |
0.7581 |
0.19002 |
connective tissue growth factor precursor (CTGF) |
| 690 |
D08d |
0.33221 |
0.83486 |
0.13016 |
thrombospondin 2 precursor (THBS2; TSP2) |
| 802 |
E02d |
0.33303 |
0.74788 |
0.19915 |
NKG5 protein precursor; lymphokine LAG2; T-cell activation protein 519 |
| 225 |
B03a |
0.33401 |
1.4339 |
0.34365 |
specific 116-kDa vacuolar proton pump subunit |
| 515 |
C09k |
0.33587 |
0.64195 |
0.285 |
signal transducer and activator of transcription 2 (STAT2); p113 |
| 803 |
E02e |
0.33589 |
0.59806 |
0.31996 |
HGF agonist/antagonist |
| 296 |
B08b |
0.33599 |
1.3872 |
0.30832 |
smoothened; GX |
| 797 |
E01m |
0.33765 |
0.8302 |
0.13581 |
HLA class II histocompability antigen alpha subunit precursor (MHC-alpha) |
| 503 |
C08m |
0.33802 |
1.1358 |
0.10871 |
glucocorticoid receptor alpha variant |
| 921 |
E10k |
0.33816 |
1.9029 |
0.72313 |
chymotrypsin-like protease CTRL-1 precursor |
| 1125 |
F11e |
0.33897 |
0.81508 |
0.14843 |
DR-nm23 |
| 1146 |
F12l |
0.33921 |
1.4499 |
0.36133 |
BENE |
| 381 |
B14c |
0.34066 |
1.1856 |
0.14966 |
glycogen synthase kinase 3 beta (GSK3 beta); tau kinase subunit; factor A |
| 1010 |
F03b |
0.34096 |
1.0921 |
0.07431 |
fibronectin precursor (FN) |
| 425 |
C03e |
0.34125 |
1.1484 |
0.11981 |
TRAF-interacting protein (hTRIP) |
| 207 |
B01k |
0.34206 |
0.80359 |
0.15896 |
cytohesin-1; Sec7p-like protein |
| 245 |
B04g |
0.34259 |
1.2117 |
0.17162 |
testis-specific protein kinase 1 |
| 169 |
A13a |
0.34319 |
1.3532 |
0.28675 |
colorectal mutant cancer protein (MCC) |
| 271 |
B06e |
0.34325 |
0.85751 |
0.11569 |
KIAA0175 |
| 152 |
A11l |
0.34482 |
1.1824 |
0.14869 |
CDC25B; CDC25HU2; M-phase inducer phosphatase 2 |
| 77 |
A06g |
0.34556 |
1.8362 |
0.68314 |
matrix metalloproteinase 10 (MMP10); stromelysin 2 precursor (STMY2; SL2); transin 2 |
| 723 |
D10i |
0.34577 |
1.2577 |
0.21067 |
cytokine receptor class II CRF2-4 precursor |
| 902 |
E09f |
0.34648 |
0.8015 |
0.16256 |
interleukin-4 precursor (IL-4); B-cell stimulatory factor 1 (BSF-1); lymphocyte stimulatory factor 1 |
| 56 |
A04n |
0.34706 |
1.7946 |
0.65173 |
Bcl2 & p53 binding protein Bbp/53BP2 (BBP/53BP2) |
| 349 |
B11m |
0.34723 |
0.82844 |
0.14078 |
FKBP-rapamycin associated protein (FRAP); rapamycin target protein |
| 141 |
A11a |
0.34992 |
1.3291 |
0.27199 |
Wilms' tumor protein (WT33; WT1) |
| 1071 |
F07g |
0.34995 |
3.5048 |
2.0704 |
myosine light chain 1 slow-twitch muscle B/ventricular isoform (MLC1SB) |
| 578 |
C14d |
0.35035 |
0.77639 |
0.18503 |
PDCD2 |
| 554 |
C12h |
0.35087 |
0.82687 |
0.14346 |
RAD51C truncated protein |
| 676 |
D07d |
0.35137 |
1.1423 |
0.1181 |
integrin beta 8 precursor (ITGB8) |
| 971 |
E14e |
0.35147 |
0.72802 |
0.22573 |
dishevelled (DVL) + dishevelled 3 (DVL3) |
| 1108 |
F10b |
0.35187 |
0.83917 |
0.13363 |
IMP dehydrogenase 1 |
| 263 |
B05k |
0.35271 |
1.2605 |
0.21693 |
CDC42 GTPase-activating protein |
| 1078 |
F07n |
0.35478 |
0.64235 |
0.29945 |
GS2 protein |
| 728 |
D10n |
0.35602 |
0.82209 |
0.14945 |
secretogranin I precursor (SGI); chromogranin B |
| 708 |
D09h |
0.3573 |
0.89044 |
0.092348 |
cation-independent mannose-6-phosphate receptor precursor (CI man-6-P receptor; CI-MPR); insulin-like growth factor II receptor (IGFR II) |
| 326 |
B10d |
0.3574 |
1.0936 |
0.078947 |
cAMP-dependent protein kinase beta-catalytic subunit (PKA C-beta) |
| 573 |
C13m |
0.35753 |
1.1696 |
0.14304 |
nuclear protein SKIP |
| 205 |
B01i |
0.35894 |
0.7945 |
0.17397 |
protein-tyrosine phosphatase 1C (PTP1C); hematopoietic cell protein-tyrosine phosphatase; SH-PTP1 |
| 496 |
C08f |
0.35964 |
0.74409 |
0.21705 |
chromodomain-helicase-DNA-binding protein 1 (CHD1) |
| 694 |
D08h |
0.36059 |
0.79232 |
0.17659 |
N-sam; fibroblast growth factor receptor1 precursor (FGFR1); basic fibroblast growth factor receptor precursor (bFGFR); fms-like tyrosine kinase-2 (FLT2) + heparin-binding growth factor receptor (HBGF-R-alpha-A1) + HBGF-R-alpha-A2 + HBGF-R-alpha-A3 |
| 37 |
A03i |
0.36093 |
1.2115 |
0.18003 |
myelodysplasia/myeloid leukemia factor 2 (MLF2) |
| 338 |
B11b |
0.36216 |
1.1895 |
0.16184 |
GRB-IR / GRB10 |
| 1163 |
F14a |
0.36321 |
1.2279 |
0.19513 |
secreted protein acidic and rich in cysteine precursor (SPARC); osteonectin (ON); basement membrane protein (BM40) |
| 325 |
B10c |
0.36417 |
1.1774 |
0.15226 |
c-jun N-terminal kinase 2 (JNK2); JNK55 |
| 923 |
E10m |
0.36568 |
1.2198 |
0.18942 |
MHC class II HLA-DR-beta (DR2-DQW1/DR4 DQW3) precursor |
| 823 |
E03k |
0.36695 |
1.5233 |
0.45248 |
placental protein 11 precursor (PP11) |
| 162 |
A12h |
0.36729 |
1.5126 |
0.44363 |
cullin homolog 2 (CUL2) |
| 1009 |
F03a |
0.36849 |
1.0762 |
0.066137 |
collagen 16 alpha 1 subunit precursor (COL16A1) |
| 1047 |
F05k |
0.36857 |
1.1494 |
0.12972 |
60S ribosomal protein L32 |
| 1061 |
F06k |
0.36995 |
1.1695 |
0.14775 |
translation initiation factor EIF-2B alpha subunit; EIF-2B GDP-GTP exchange factor |
| 1144 |
F12j |
0.37038 |
0.89408 |
0.092422 |
elongation factor 1 alpha (EF1 alpha) |
| 794 |
E01j |
0.37099 |
0.84398 |
0.13635 |
matrix metalloproteinase 13 (MMP13); collagenase 3 precursor |
| 188 |
A14f |
0.37134 |
1.5639 |
0.49323 |
p33ING1 |
| 95 |
A07k |
0.37266 |
1.23 |
0.20185 |
serine/threonine-protein kinase NEK3; NIMA-related protein kinase 3; HSPK 36 |
| 613 |
D02k |
0.37321 |
0.80833 |
0.16849 |
nuclear hormone receptor |
| 238 |
B03n |
0.3751 |
0.76656 |
0.20623 |
T3 receptor-associating cofactor 1 |
| 57 |
A05a |
0.37689 |
1.2817 |
0.25002 |
neurofibromatosis protein type I (NF1); neurofibromin |
| 843 |
E05c |
0.37792 |
0.85412 |
0.12983 |
teratocarcinoma-derived growth factor 1 (TDGF1); epidermal growth factor-like CRIPTO protein CR1; CRIPTO-1 growth factor (CRGF) + teratocarcinoma-derived growth factor 3 (TDGF3); epidermal growth factor-like CRIPTO protein CR3; CRIPTO-3 growth factor (CRG |
| 131 |
A10e |
0.37799 |
2.3213 |
1.1761 |
C-fes proto-oncogene |
| 793 |
E01i |
0.37811 |
1.3097 |
0.2758 |
Wnt-10B precursor; Wnt-12 |
| 192 |
A14j |
0.37824 |
1.4994 |
0.44479 |
CDC-like kinase 1 (CLK1) |
| 130 |
A10d |
0.37853 |
1.2431 |
0.21669 |
met proto-oncogene; hepatocyte growth factor receptor precursor (HGF-SF receptor) |
| 305 |
B08k |
0.37863 |
1.0934 |
0.083284 |
rho-GAP hematopoietic protein C1 (RGC1); KIAA0131 |
| 310 |
B09b |
0.3791 |
0.84655 |
0.13699 |
Putative rho/rac guanine nucleotide exchange factor (rho/rac GEF); faciogenital dysplasia protein (FGD1) |
| 332 |
B10j |
0.38002 |
0.87059 |
0.11581 |
Rho-related GTP-binding protein RhoE; Rho8; ARHE |
| 567 |
C13g |
0.38063 |
1.1274 |
0.11416 |
DNA-repair protein complementing XP-A cells; xeroderma pigmentosum group A complementing protein |
| 706 |
D09f |
0.38136 |
0.87297 |
0.11408 |
beta 3-endonexin |
| 899 |
E09c |
0.38145 |
0.82904 |
0.15357 |
acidic fibroblast growth factor (AFGF) + heparin-binding growth factor 1 precursor (HBGF-1) + beta-endothelial cell growth factor (ECGF-beta) |
| 905 |
E09i |
0.38411 |
1.356 |
0.32201 |
matrix metalloproteinase 8 (MMP8); neutrophil collagenase precursor (CLG1); PMNL collagenase (PMNL-CL) |
| 1057 |
F06g |
0.38632 |
4.5474 |
3.2272 |
hyaluronan receptor (RHAMM) |
| 346 |
B11j |
0.38947 |
0.91213 |
0.080599 |
rhoHP1 |
| 825 |
E03m |
0.38968 |
0.75631 |
0.22366 |
HLA-DPB1 precursor; HLA class II histocompability antigen SB beta chain |
| 403 |
C01k |
0.39023 |
1.5093 |
0.46809 |
homeobox protein HOX-D3; HOX-4A |
| 163 |
A12i |
0.39132 |
1.176 |
0.16222 |
cyclin G2 (CCNG2) |
| 434 |
C03n |
0.39147 |
0.78759 |
0.19586 |
E4BP4 |
| 1034 |
F04l |
0.39294 |
0.78339 |
0.2005 |
KIAA0324 |
| 627 |
D03k |
0.39401 |
2.9946 |
1.8514 |
low-affinity nerve growth factor receptor (NGF receptor; NGFR); GP80-LNGFR |
| 421 |
C03a |
0.39506 |
1.1434 |
0.13344 |
tumor necrosis factor receptor (TNFR) + tumor necrosis factor receptor 2 (TNFR2); tumor necrosis factor binding protein 2 (TBP2) |
| 347 |
B11k |
0.39545 |
0.71774 |
0.26298 |
phosphatidylinositol 3-kinase regulatory alpha subunit (PTDINS-3-kinase P85-alpha; PI3-kinase P85-alpha) |
| 850 |
E05j |
0.396 |
1.6363 |
0.59365 |
plasminogen precursor (PLG) |
| 501 |
C08k |
0.39689 |
0.79858 |
0.18837 |
signal transducer and activator of transcription 1 alpha/beta (STAT1); transcription factor ISGF-3 components p91/p84 |
| 84 |
A06n |
0.39833 |
0.88873 |
0.10445 |
NEDD5 protein homolog; DIFF6; KIAA0158 |
| 102 |
A08d |
0.39856 |
1.5316 |
0.49932 |
macrophage colony stimulating factor I receptor precursor (CSF-1-R); fms proto-oncogene (c-fms); CD115 |
| 866 |
E06l |
0.3987 |
1.2542 |
0.23882 |
KIAA0093 |
| 60 |
A05d |
0.40055 |
1.2085 |
0.19685 |
c-raf proto-oncogene |
| 1111 |
F10e |
0.40056 |
0.83991 |
0.15115 |
adenosine deaminase (ADA); adenosine aminohydrolase |
| 334 |
B10l |
0.40066 |
0.87261 |
0.12031 |
gonadotropin-releasing hormone receptor (GNRHR) |
| 312 |
B09d |
0.40089 |
0.77292 |
0.21459 |
casein kinase I gamma 2 (CKI-gamma 2) |
| 1022 |
F03n |
0.40097 |
0.74435 |
0.24164 |
KIAA0204 |
| 584 |
C14j |
0.40152 |
1.173 |
0.16379 |
I-rel (RELB) |
| 744 |
D12b |
0.40288 |
0.77181 |
0.21676 |
AC133 antigen |
| 641 |
D04k |
0.40347 |
4.4277 |
3.261 |
GABA-B receptor 1A subunit (GABA-BR1A ) |
| 2 |
A01b |
0.40348 |
1.2196 |
0.20897 |
ras-related protein RAP-1A; C21KG; KREV-1 protein; GTP-binding protein SMG-p21A; G-22K |
| 924 |
E10n |
0.40586 |
0.89118 |
0.10418 |
collagen 4 alpha 3 subunit precursor (COL4A3) |
| 860 |
E06f |
0.40628 |
0.91783 |
0.078745 |
interleukin-1 alpha precursor (IL-1 alpha; IL1A); hematopoietin-1 |
| 644 |
D04n |
0.40751 |
0.70708 |
0.28163 |
cytochrome B-245 heavy chain; P22 phagocyte B-cytochrome; neutrophil cytochrome B 91-kDa polypeptide; CGD91-PHOX; cytochrome B(558) beta subunit; superoxide-generating NADPH oxidase heavy chain subunit |
| 543 |
C11k |
0.40894 |
1.1615 |
0.15585 |
signal transducer and activator of transcription 4 (STAT4) |
| 1048 |
F05l |
0.40955 |
1.2261 |
0.21851 |
KIAA0022 GENE |
| 81 |
A06k |
0.40988 |
1.4145 |
0.401 |
CDC2-related protein kinase CHED |
| 14 |
A01n |
0.41035 |
0.95612 |
0.042503 |
RBQ1 retinoplastoma binding protein |
| 961 |
E13i |
0.41179 |
1.1046 |
0.1017 |
matrix metalloproteinase 15 (MMP15); membrane-type matrix metalloproteinase 2 (MT-MMP2) |
| 200 |
B01d |
0.41243 |
0.75049 |
0.24297 |
p21-activated kinase alpha (PAK-alpha; PAK1) |
| 726 |
D10l |
0.41381 |
1.2387 |
0.23333 |
orphan G protein-coupled receptor 39 (GPR39) |
| 978 |
E14l |
0.41646 |
2.3241 |
1.303 |
immunoglobulin-related 14.1 protein precursor |
| 611 |
D02i |
0.41767 |
1.9169 |
0.90512 |
NT-3 growth factor receptor precursor (NTRK3); C-trk tyrosine kinase (TRKC) |
| 777 |
D14g |
0.41876 |
1.8289 |
0.82058 |
desmocollin 3A/3B precursor (DSC3) + desmocollin 4 (DSC4) |
| 592 |
D01d |
0.41977 |
2.7536 |
1.7406 |
cadherin 3 (CDH3); placental cadherin precursor (P-cadherin; CDHP) |
| 420 |
C02n |
0.42178 |
0.88267 |
0.11707 |
IkappaB epsilon (IKBE) |
| 39 |
A03k |
0.42202 |
0.93227 |
0.067619 |
cell division protein kinase 9 (CDK9); serine/threonine protein kinase PITALRE |
| 591 |
D01c |
0.42212 |
34.754 |
33.708 |
melanocyte protein PMEL 17 precursor; melanocyte lineage-specific antigen GP100; melanoma-associated ME20 antigen; 95-kDa melanocyte-specific secreted glycoprotein |
| 722 |
D10h |
0.42244 |
518.83 |
517.55 |
ephrin type-B receptor 2 precursor; tyrosine-protein kinase receptor EPH-3; DRT; HEK; ERK |
| 376 |
B13l |
0.42284 |
629.38 |
628.69 |
HRS |
| 371 |
B13g |
0.42296 |
72.838 |
71.896 |
type II cGMP-dependent protein kinase |
| 521 |
C10c |
0.42394 |
1.1726 |
0.17319 |
DNA fragmentation factor 45 (DFF45) |
| 660 |
D06b |
0.42519 |
0.93348 |
0.06696 |
nonhistone chromosomal protein HMG17 |
| 385 |
B14g |
0.42706 |
1.1287 |
0.13019 |
cGMP-dependent protein kinase beta (CGK); type I alpha cGMP-dependent protein kinase |
| 437 |
C04c |
0.43128 |
0.90259 |
0.099616 |
apoptosis regulator bax |
| 89 |
A07e |
0.43166 |
1.2725 |
0.27893 |
tyrosine-protein kinase ABL2; tyrosine kinase ARG (ABLL) |
| 199 |
B01c |
0.43327 |
1.2124 |
0.21831 |
dual-specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1; MAPKK 1; MKK1); extracellular signal-regulated kinase 1; ERK activator kinase 1 |
| 1001 |
F02g |
0.43394 |
1.7995 |
0.82331 |
type II cytoskeletal 7 keratin (KRT7); cytokeratin 7 (K7; CK7) |
| 864 |
E06j |
0.43417 |
1.2546 |
0.26235 |
leukocyte elastase inhibitor (LEI); monocyte/neutrophil elastase inhibitor) (EI) |
| 714 |
D09n |
0.43483 |
1.3477 |
0.35884 |
glial cell line-derived neurotropic factor precursor (GDNF) |
| 454 |
C05f |
0.43647 |
0.88107 |
0.12328 |
MCM2 DNA replication licensing factor; nuclear protein BM28; KIAA0030 |
| 604 |
D02b |
0.43709 |
1.2031 |
0.21088 |
histone deaceytlase 2 (HD2) |
| 471 |
C06i |
0.43805 |
1.3851 |
0.40081 |
recA-like protein HsRad51; DNA repair protein RAD51 homolog |
| 1043 |
F05g |
0.43855 |
0.89735 |
0.10698 |
desmin (DES) |
| 1139 |
F12e |
0.43876 |
0.8665 |
0.13921 |
microsomal UDP-glucuronosyltransferase 2B15 precursor (UDPGT); UDPGTH-3; UGT2B15 + microsomal 2B10 precursor (UDPGT); UGT2B10 + 2microsomal B8 precursor |
| 605 |
D02c |
0.43881 |
4.6139 |
3.7689 |
lymphocyte antigen |
| 682 |
D07j |
0.44295 |
1.7713 |
0.81308 |
interferon gamma receptor (IFNGR) |
| 331 |
B10i |
0.44356 |
1.2501 |
0.26405 |
protein phosphatase WIP1 |
| 643 |
D04m |
0.44374 |
1.4662 |
0.49245 |
low-density lipoprotein receptor-related protein 2 precursor (LRP2); megalin |
| 586 |
C14l |
0.44389 |
1.6647 |
0.70245 |
putative transcription regulatory protein HRC1 |
| 86 |
A07b |
0.44499 |
1.5985 |
0.63429 |
tight junction protein zonula occludens (ZO-1); tight junction protein 1 (TJP1) |
| 369 |
B13e |
0.44895 |
1.1952 |
0.20901 |
serine/threonine-protein kinase PCTAIRE 3 (PCTK3) |
| 781 |
D14k |
0.4491 |
2.0367 |
1.1105 |
low affinity immunoglobulin gamma FC receptor II-A precursor (FC-gamma RII-A; FCRII-A; IgG FC receptor II-A); CD32 antigen |
| 800 |
E02b |
0.44949 |
0.70503 |
0.3163 |
cytokine humig; interferon-gamma-induced monokine (MIG) |
| 795 |
E01k |
0.45069 |
1.2033 |
0.21872 |
cathepsin L precursor; major excreted protein (MEP) |
| 34 |
A03f |
0.4507 |
1.1506 |
0.16196 |
C-cbl proto-oncogene |
| 358 |
B12h |
0.45105 |
1.3343 |
0.35996 |
protein phosphatase PP2A 61-kDa regulatory subunit episilon |
| 807 |
E02i |
0.45229 |
1.1462 |
0.15787 |
CD9 antigen; p24; leukocyte antigen MIC3; motility-related protein (MRP-1) |
| 602 |
D01n |
0.4524 |
1.2175 |
0.23505 |
endothelial tumor necrosis factor alpha-induced protein 1; B12 protein |
| 25 |
A02k |
0.45286 |
0.79105 |
0.22603 |
serine/threonine-protein kinase PLK1 (STPK13) |
| 459 |
C05k |
0.45351 |
0.75427 |
0.26627 |
purine-rich single-stranded DNA-binding protein alpha (PURA) |
| 817 |
E03e |
0.4544 |
0.62707 |
0.40504 |
competitive hepatocyte growth factor antagonist (HGF antagonist) |
| 293 |
B07m |
0.4549 |
0.8676 |
0.14399 |
zyxin + zyxin-2 |
| 853 |
E05m |
0.45546 |
1.3122 |
0.33999 |
immunoglobulin rearranged gamma chain (IgG) + immunoglobulin kappa chain constant region (IgGK) |
| 697 |
D08k |
0.45772 |
3.8904 |
3.1667 |
DNAX activation protein 12 |
| 1038 |
F05b |
0.45795 |
0.91291 |
0.095467 |
interferon-gamma IEF SSP 5111 |
| 304 |
B08j |
0.4583 |
0.86551 |
0.14757 |
ras-like small GTPase TTF |
| 234 |
B03j |
0.45929 |
1.1485 |
0.16332 |
CDC42 homolog; G25K GTP-binding protein (brain isoform + placental isoform) |
| 593 |
D01e |
0.46029 |
1.2498 |
0.27547 |
integrin alpha 4 precursor (ITGA4); VLA4; CD49D antigen |
| 407 |
C02a |
0.46055 |
1.812 |
0.89616 |
tumor necrosis factor receptor 1 (TNFR1); tumor necrosis factor binding protein 1 (TBP1); CD120A antigen |
| 827 |
E04a |
0.467 |
0.84936 |
0.1691 |
bone morphogenetic protein 2A (BMP2A) |
| 826 |
E03n |
0.46993 |
0.75547 |
0.2766 |
cartilage-specific proteoglycan core protein (CSPCP); aggrecan core protein precursor (AGC1); chondroitin sulfate proteoglycan core protein 1 (CSPG1) |
| 556 |
C12j |
0.47137 |
0.76867 |
0.26266 |
early growth response protein 1 (hEGR1); transcription factor ETR103; KROX24; zinc finger protein 225; AT225 |
| 575 |
C14a |
0.47273 |
0.86059 |
0.15886 |
TRAF6 |
| 551 |
C12e |
0.47275 |
0.85339 |
0.16707 |
DNA topoisomerase II alpha (TOP2A) |
| 1068 |
F07d |
0.473 |
0.83761 |
0.18517 |
CTP synthase; UTP-ammonia ligase; CTP synthetase |
| 998 |
F02d |
0.47334 |
0.87361 |
0.14425 |
branched-chain amino acid aminotransferase mitochondrial precursor (BCAT(M)) |
| 631 |
D04a |
0.47475 |
1.503 |
0.57628 |
interferon regulatory factor 5 (IRF-5) DNA-binding nuclear protein |
| 1052 |
F06b |
0.47662 |
0.79086 |
0.24076 |
aldehyde oxidase (hAOX) |
| 64 |
A05h |
0.47747 |
1.2126 |
0.24534 |
notch2 |
| 258 |
B05f |
0.47754 |
0.6862 |
0.36212 |
serine/threonine protein kinase |
| 382 |
B14d |
0.47921 |
0.90303 |
0.1124 |
ribosomal protein S6 kinase II alpha 2 (S6KII-alpha 2); ribosomal S6 kinase 3 (RSK3) |
| 914 |
E10d |
0.47927 |
0.83331 |
0.19324 |
bone morphogenetic protein 7 precursor (BMP7); osteogenic protein 1 (OP1) |
| 309 |
B09a |
0.47968 |
1.4076 |
0.47304 |
tyrosine-protein kinase HCK; P59-HCK & P60-HCK; hemopoietic cell kinase |
| 174 |
A13f |
0.48222 |
1.3584 |
0.41874 |
malignant melanoma metastasis-suppressor (KiSS-1) gene |
| 93 |
A07i |
0.48258 |
1.3819 |
0.44661 |
G1/S-specific cyclin D2 (CCND2) + KIAK0002 |
| 1007 |
F02m |
0.48297 |
0.84307 |
0.18371 |
brain secretory protein 10P (hSEC10P) |
| 689 |
D08c |
0.48454 |
1.1878 |
0.22079 |
preferentially expressed antigen of melanoma |
| 625 |
D03i |
0.48566 |
1.4604 |
0.54286 |
vascular endothelial growth factor receptor 3 precursor (VEGFR3); tyrosine-protein kinase receptor FLT4 |
| 705 |
D09e |
0.48636 |
1.1451 |
0.17142 |
beta catenin (CTNNB) |
| 819 |
E03g |
0.48639 |
0.83253 |
0.19782 |
interleukin-11 (IL-11); adipogenesis inhibitory factor (AGIF) |
| 133 |
A10g |
0.49075 |
1.4064 |
0.4856 |
PIG3 |
| 1015 |
F03g |
0.4913 |
0.92227 |
0.09302 |
type II cytoskeletal 8 keratin (KRT8); cytokeratin 8 (K8; CK8) |
| 559 |
C12m |
0.49474 |
1.2892 |
0.34933 |
CREB-binding protein |
| 21 |
A02g |
0.49782 |
1.249 |
0.3032 |
neurogenic locus notch protein (N) |
| 157 |
A12c |
0.49877 |
1.1779 |
0.21718 |
fos-related antigen 2 (FRA2) |
| 1100 |
F09h |
0.49965 |
1.2069 |
0.25313 |
TRAM protein |
| 814 |
E03b |
0.50062 |
1.0681 |
0.0836 |
hepatocyte growth factor activator (HGF activator) |
| 986 |
F01f |
0.50117 |
0.97625 |
0.02918 |
beta-spectrin (SPTB) |
| 105 |
A08g |
0.50131 |
0.90712 |
0.11416 |
metalloproteinase inhibitor 3 precursor; tissue inhibitor of metalloproteinases 3 (TIMP3); mitogen-inducible gene 5 (MIG5) |
| 831 |
E04e |
0.50166 |
0.84222 |
0.1941 |
interferon gamma antagonist (IFN-gamma antagonist) |
| 1086 |
F08h |
0.50236 |
1.2745 |
0.33829 |
SEC7 homolog B2-1 |
| 542 |
C11j |
0.50284 |
0.85957 |
0.1733 |
octamer-binding transcription factor 2 (oct-2; OTF2); lymphoid-restricted immunoglobulin octamer binding protein NF-A2; POU2F2 |
| 917 |
E10g |
0.50576 |
0.89045 |
0.13625 |
melanoma differentiation-associated protein 7 precursor (MDA7) |
| 61 |
A05e |
0.50828 |
0.80376 |
0.24573 |
c-ros-1 tyrosine-protein kinase proto-oncogene |
| 143 |
A11c |
0.50967 |
1.1488 |
0.18707 |
B-myb |
| 41 |
A03m |
0.51046 |
0.90425 |
0.12059 |
cyclin-dependent kinase 5 activator isoform p39I precursor (CDK5 activator; NCK5AI) |
| 299 |
B08e |
0.51093 |
0.94052 |
0.075006 |
p21-activated kinase gamma (PAK-gamma; PAK2); PAK65; S6/H4 kinase |
| 537 |
C11e |
0.51339 |
0.7505 |
0.31674 |
DNA topoisomerase I (TOP1) |
| 38 |
A03j |
0.51352 |
1.0847 |
0.10752 |
cyclin-dependent protein kinase 2 (CDK2); p33 protein kinase |
| 297 |
B08c |
0.5173 |
1.1053 |
0.13514 |
cAMP-dependent protein kinase I alpha regulatory subunit; tissue-specific extinguisher 1 (TSE1) |
| 622 |
D03f |
0.51819 |
0.83737 |
0.20914 |
platelet membrane glycoprotein IA precursor (GPIA); collagen receptor; integrin alpha 2 (ITGA2); very late antigen-2 alpha subunit (VLA2); CD49B antigen |
| 137 |
A10k |
0.51832 |
0.85055 |
0.19227 |
cyclin-dependent kinase regulatory subunit 1 (CKS1) |
| 465 |
C06c |
0.51915 |
1.1445 |
0.18625 |
apoptosis regulator bclw; KIAA0271; BCL2L2 |
| 733 |
D11e |
0.5194 |
0.83507 |
0.2128 |
polycystin precursor; autosomal dominant polycystic kidney disease protein 1 |
| 910 |
E09n |
0.51955 |
0.79321 |
0.26691 |
collagen 4 alpha 2 subunit precursor (COL4A2) |
| 401 |
C01i |
0.51994 |
1.2254 |
0.29128 |
DNA repair protein XRCC4 |
| 1173 |
F14k |
0.52001 |
0.84505 |
0.20024 |
IGFBP complex acid labile chain |
| 148 |
A11h |
0.52133 |
1.2237 |
0.29012 |
box-dependent myc-interacting protein 1 |
| 763 |
D13g |
0.5224 |
1.2066 |
0.26873 |
desmocollin 1A/1B precursor (DSC1); desmosomal glycoprotein 2/3 (DG2/DG3) |
| 870 |
E07b |
0.52396 |
0.77656 |
0.29187 |
thrombopoietin precursor (THPO); megakaryocyte colony stimulating factor; c-mpl ligand; megakaryocyte growth & development factor (MGDF) |
| 724 |
D10j |
0.52414 |
1.2207 |
0.2885 |
IL-17 receptor |
| 507 |
C09c |
0.52476 |
0.84848 |
0.19836 |
bcl-2 interacting killer (BIK); NBK apoptotic inducer protein; BP4; BIP1 |
| 636 |
D04f |
0.52529 |
1.1978 |
0.25931 |
integrin alpha 8 (ITGA8) |
| 283 |
B07c |
0.52605 |
1.2557 |
0.33593 |
myosin light chain kinase (MLCK) smooth muscle & non-muscle isozymes |
| 373 |
B13i |
0.52623 |
0.87835 |
0.1599 |
ras-related C3 botulinum toxin substrate 1; p21-rac1; ras-like protein TC25 |
| 1002 |
F02h |
0.52813 |
1.1682 |
0.22227 |
growth-arrest-specific protein 2 (GAS2) |
| 372 |
B13h |
0.52854 |
0.85019 |
0.19815 |
protein phosphatase with EF-hands-2 long form (PPEF2) |
| 840 |
E04n |
0.52961 |
0.74943 |
0.3324 |
bone/cartilage proteoglycan 1 precursor; biglycan (BGN); PGS1 |
| 700 |
D08n |
0.53103 |
1.1982 |
0.26388 |
neurotrophin-4 (NT4); NT5 + NT6-alpha + NT6-beta + NT6-gamma |
| 684 |
D07l |
0.53307 |
2.0775 |
1.4429 |
ephrin type-B receptor 1 precursor; tyrosine-protein kinase receptor EPH-2; NET |
| 227 |
B03c |
0.53434 |
1.1542 |
0.2072 |
dual specificity mitogen-activated protein kinase kinase 5 (MAP kinase kinase 5; MAPKK 5) |
| 881 |
E07m |
0.53449 |
1.3286 |
0.44175 |
HLA-DR antigen-associated invariant subunit |
| 564 |
C13d |
0.53519 |
0.86959 |
0.17565 |
apoptosis inhibitor survivin |
| 1064 |
F06n |
0.53913 |
1.1614 |
0.21981 |
early growth response alpha (EGR alpha) |
| 513 |
C09i |
0.53927 |
0.91757 |
0.11228 |
growth arrest & DNA-damage-inducible protein (GADD45); DNA-damage-inducible transcript 1 (DDIT1) |
| 695 |
D08i |
0.54015 |
1.4492 |
0.61337 |
G protein-coupled receptor bonzo; STRL33 |
| 447 |
C04m |
0.54099 |
0.89476 |
0.14403 |
cholecystokinin A receptor (CCKA receptor; CCKAR) |
| 703 |
D09c |
0.54114 |
0.92691 |
0.10008 |
autoimmunogenic cancer/testis antigen NY-ESO-1; LAGE-1 |
| 87 |
A07c |
0.54197 |
1.1909 |
0.26203 |
erythroblastosis virus oncogene homolog 1 (ETS-1); p54 |
| 288 |
B07h |
0.54342 |
0.87272 |
0.17537 |
dual-specificity protein phosphatase 2; PAC-1 |
| 517 |
C09m |
0.54347 |
1.3275 |
0.45133 |
aryl hydrocarbon receptor (AH receptor) |
| 366 |
B13b |
0.54447 |
1.1097 |
0.15158 |
epidermal growth factor receptor kinase substrate EPS8 |
| 110 |
A08l |
0.54718 |
1.1927 |
0.26835 |
cyclin-dependent kinase inhibitor 1C (CDKN1C); p57-KIP2 |
| 1063 |
F06m |
0.54885 |
1.0774 |
0.10823 |
interferon-induced 56-kDa protein (IFI-56K) |
| 1150 |
F13b |
0.55077 |
0.83383 |
0.23368 |
cytosolic serine hydroxylmethyltransferase (SHMT) |
| 469 |
C06g |
0.55173 |
1.478 |
0.67402 |
xeroderma pigmentosum group B complementing protein (XPB); DNA excision repair protein ERCC3; basal transcription factor 2 89-kDa subunit (BTF2-p89); TFIIH 89-kDa subunit |
| 160 |
A12f |
0.55271 |
1.1072 |
0.15157 |
synapse-associated protein 102 (SAP102); neuroendocrine-DLG (NE-DLG; DLG3; human homolog of Drosophila discs large (DLG)) |
| 895 |
E08m |
0.55276 |
1.118 |
0.16688 |
glioma pathogenesis-related protein; RTVP-1 protein |
| 531 |
C10m |
0.55311 |
0.92597 |
0.10479 |
TAX1-binding protein 151 (TXBP151) |
| 528 |
C10j |
0.55321 |
0.89235 |
0.15242 |
interferon consensus sequence-binding protein (ICSBP) |
| 168 |
A12n |
0.55389 |
1.1121 |
0.15902 |
G1 to S phase transition protein 1 homolog; GTP-binding protein GST1-HS |
| 493 |
C08c |
0.55537 |
0.8618 |
0.19686 |
BCL-2-related protein A1 (BCL2A1); BFL1 protein; hemopoietic-specific early response protein; GRS protein |
| 638 |
D04h |
0.55707 |
1.4135 |
0.5918 |
erythropoietin receptor (EPOR) |
| 789 |
E01e |
0.55731 |
0.74118 |
0.3707 |
glia-activating factor precursor (GAF); fibroblast growth factor 9 (FGF9); HBGF9 |
| 412 |
C02f |
0.55762 |
1.1819 |
0.26077 |
replication factor C 36-kDa subunit (RFC36); activator 1 36-kDa subunit |
| 1112 |
F10f |
0.55829 |
1.1877 |
0.26952 |
type II cytoskeletal 11 keratin (KRT11); cytokeratin 1 (K1; CK1); 67-kDa cytokeratin; hair alpha protein |
| 178 |
A13j |
0.55835 |
0.86598 |
0.19252 |
serine/threonine-protein kinase NEK2; NIMA-related protein kinase 2; NIMA-like protein kinase 1; HSPK 21 |
| 285 |
B07e |
0.5593 |
1.16 |
0.23043 |
rho-associated coiled-coil containing protein kinase p160ROCK |
| 530 |
C10l |
0.55931 |
0.87246 |
0.1837 |
Krueppel-related zinc finger protein |
| 410 |
C02d |
0.56269 |
1.1116 |
0.16231 |
SL cytokine precursor; FLT3 ligand (FLT3LG) |
| 806 |
E02h |
0.56376 |
1.3497 |
0.51007 |
ephrin-B3 precursor; eph-related receptor tyrosine kinase ligand 8 (LERK-8); eph-related receptor transmembrane ligand ELK-L3 |
| 189 |
A14g |
0.56485 |
1.3458 |
0.50589 |
PIG12 |
| 439 |
C04e |
0.56557 |
1.0767 |
0.11251 |
"casper, a FADD- and caspase-related inducer of apoptosis (CASH-alpha + CASH-beta); FLAME-1; FLICE-like inhibitory protein" |
| 987 |
F01g |
0.56664 |
1.2658 |
0.39087 |
type II cytoskeletal 6 keratin: cytokeratin 6A (CK6A); K6A keratin (KRT6A) + CK6B; KRT6B + CK6C; KRT6C + CK6D; KRT6D + CK6E; KRT6E + CK6F; KRT6F |
| 337 |
B11a |
0.56714 |
1.0692 |
0.10191 |
c-fer proto-oncogene |
| 232 |
B03h |
0.56729 |
1.0704 |
0.10377 |
serine/threonine protein kinase SAK |
| 619 |
D03c |
0.56848 |
1.0922 |
0.13634 |
natural killer cell protein 7 (NKG7); protein GIG1 |
| 616 |
D02n |
0.57214 |
1.1412 |
0.2109 |
(2'-5')oligoadenylate synthetase 1 ((2-5')oligo(A) synthetase 1; 2-5A synthetase 1) |
| 698 |
D08l |
0.57476 |
0.7955 |
0.30776 |
ephrin type-B receptor 4 precursor; tyrosine-protein kinase receptor HTK |
| 94 |
A07j |
0.575 |
1.2178 |
0.32798 |
protein serine/threonine kinase STK1; cell division protein kinase 7 (CDK7); CDK-activating kinase (CAK); 39-kDa protein kinase |
| 874 |
E07f |
0.57527 |
0.86523 |
0.20313 |
interleukin-1 beta precursor (IL-1 ; IL1B); catabolin |
| 773 |
D14c |
0.5755 |
0.77682 |
0.3366 |
OX2 membrane glycoprotein precursor |
| 97 |
A07m |
0.57587 |
1.2517 |
0.38002 |
cell cycle progression restoration protein 8 (CPR8) |
| 329 |
B10g |
0.57645 |
1.0995 |
0.15049 |
B-lymphocyte germinal center kinase (GC kinase) |
| 235 |
B03k |
0.57741 |
0.89693 |
0.1563 |
caveolin-2 |
| 218 |
B02h |
0.57744 |
1.3317 |
0.50307 |
protein kinase DYRK3 |
| 790 |
E01f |
0.57972 |
1.1313 |
0.20043 |
fibroblast growth factor 5 precursor (FGF5); HBGF5 |
| 13 |
A01m |
0.58165 |
1.1107 |
0.16996 |
bullous pemphigoid antigen 1 (BPAG1; BPA); hemidesmosomal plaque protein |
| 603 |
D02a |
0.58328 |
1.2209 |
0.34068 |
LAF-4 protein; lymphoid nuclear protein |
| 523 |
C10e |
0.58508 |
1.3218 |
0.49899 |
DNA polymerase alpha catalytic subunit (POLA) |
| 993 |
F01m |
0.58533 |
1.1037 |
0.16089 |
clones 23920 & 23921 (Soares library 1NIB from IMAGE Consortium) |
| 282 |
B07b |
0.58546 |
1.1923 |
0.29846 |
protein kinase A anchoring protein |
| 540 |
C11h |
0.59114 |
0.92363 |
0.12054 |
torsina; DYT1 |
| 1181 |
G29 |
0.59118 |
0.81935 |
0.28516 |
brain-specific tubulin alpha 1 subunit (TUBA1) |
| 179 |
A13k |
0.59122 |
0.81905 |
0.28567 |
aurora- & IPL1-like midbody-associated protein kinase 1 (AIM1); ARK2 |
| 1013 |
F03e |
0.59138 |
0.93792 |
0.098044 |
fatty acid synthase |
| 721 |
D10g |
0.59171 |
0.92196 |
0.12338 |
desmoplakin I & II (DSP; DPI & DPII) |
| 732 |
D11d |
0.59239 |
1.079 |
0.12509 |
neural cell adhesion molecule phosphatidylinositol-linked isoform precursor (NCAM120); CD56 antigen |
| 1011 |
F03c |
0.59275 |
0.90371 |
0.15269 |
arachidonate 5-lipoxygenase |
| 313 |
B09e |
0.59343 |
1.2843 |
0.4517 |
stress-activated protein kinase 4 (SAPK4) |
| 356 |
B12f |
0.59461 |
1.1314 |
0.20947 |
serine/threonine protein kinase KRS2 |
| 746 |
D12d |
0.59464 |
0.92209 |
0.12424 |
desmoglein 2 precursor (DSG2); HDGC |
| 1160 |
F13l |
0.5957 |
1.4144 |
0.66288 |
reinoic acid- & interferon-inducible 58K protein RI58 |
| 112 |
A08n |
0.59677 |
0.92706 |
0.11705 |
cell cycle protein P38-2G4 homolog; HG4-1 |
| 117 |
A09e |
0.59736 |
1.2559 |
0.4114 |
C-yes proto-oncogene (YES1) |
| 198 |
B01b |
0.59789 |
1.1658 |
0.26688 |
epidermal growth factor receptor substrate 15 (EPS15); AF-1P protein |
| 279 |
B06m |
0.59841 |
0.93849 |
0.099182 |
FRAP-related protein; protein kinase ATR |
| 560 |
C12n |
0.59861 |
0.82608 |
0.28061 |
checkpoint suppressor 1 |
| 51 |
A04i |
0.60079 |
1.3121 |
0.50684 |
G2/mitotic-specific cyclin A (CCNA; CCN1) |
| 610 |
D02h |
0.60259 |
0.81432 |
0.30316 |
delta catenin |
| 256 |
B05d |
0.60273 |
0.95807 |
0.068489 |
Janus kinase 2 (JAK2); receptor-associated tyrosine kinase |
| 43 |
A04a |
0.60292 |
1.092 |
0.1503 |
p53-associated mdm2 protein |
| 816 |
E03d |
0.60451 |
1.0882 |
0.14489 |
nerve growth factor-inducible PC4 homolog |
| 869 |
E07a |
0.60507 |
0.86588 |
0.22062 |
bone morphogenetic protein 5 precursor (BMP5) |
| 190 |
A14h |
0.60598 |
1.2679 |
0.44191 |
CD82 antigen; inducible membrane protein R2; C33 antigen; metastasis suppressor kangai 1; suppressor of tumorigenicity 6 |
| 365 |
B13a |
0.60638 |
1.1766 |
0.29166 |
proto-oncogene tyrosine-protein kinase lck; p56-lck; lymphocyte-specific protein tyrosine kinase (LSK); T-cell-specific protein-tyrosine kinase |
| 1016 |
F03h |
0.6064 |
1.0592 |
0.097727 |
cardiac ventricular myosin light chain 2 |
| 701 |
D09a |
0.60687 |
1.1066 |
0.17624 |
histone deaceytlase 3C |
| 146 |
A11f |
0.60852 |
1.195 |
0.32412 |
putative oral tumor suppressor protein; DOC-1 |
| 1014 |
F03f |
0.60879 |
1.1796 |
0.29871 |
type I cytoskeletal 10 keratin; cytokeratin 10 (K10) |
| 111 |
A08m |
0.61019 |
1.1692 |
0.2826 |
protein D123 |
| 62 |
A05f |
0.6112 |
0.78779 |
0.35559 |
mas proto-oncogene |
| 770 |
D13n |
0.61175 |
0.89106 |
0.18285 |
semaphorin III (HSEM III) |
| 678 |
D07f |
0.61304 |
1.273 |
0.45992 |
integrin beta 7 precursor (ITGB7) |
| 139 |
A10m |
0.61313 |
1.086 |
0.14495 |
CDC10 protein homolog |
| 1073 |
F07i |
0.61566 |
0.90458 |
0.16208 |
heterogeneous nuclear ribonucleoprotein K (HNRNPK); dC-stretch-binding protein (CSBP); transformation-upregulated nuclear protein |
| 907 |
E09k |
0.61574 |
1.2025 |
0.34397 |
ubiquitin C-terminal hydrolase 6; ubiquitin thiolesterase 6; ubiqutin-specific processing protease 6; deubiquitinating enzyme 6; tre2 protein-oncogene |
| 647 |
D05c |
0.6161 |
1.1804 |
0.3069 |
natural killer cell anitgen CD94; KP43; killer cell lectin-like receptor subfamily D member 1 |
| 265 |
B05m |
0.6188 |
0.83424 |
0.28426 |
SH3P18 SH3 domain-containing protein |
| 80 |
A06j |
0.62129 |
1.1626 |
0.281 |
cell division protein kinase 5 (CDK5); tau protein kinase II catalytic subunit (TPKII catalytic subunit); serine/threonine protein kinase PSSALRE |
| 776 |
D14f |
0.6224 |
1.3634 |
0.63011 |
transient axonal glycoprotein 1 (TAX1; TAG1); axonin 1 |
| 267 |
B06a |
0.62307 |
1.1086 |
0.18871 |
insulin-like growth factor binding protein 5 precursor (IGF-binding protein 5; IGFBP5; IBP5) |
| 361 |
B12k |
0.62404 |
0.88739 |
0.19626 |
phospholipase D1 (PLD 1); choline phosphatase 1; phosphatidylcholine-hydrolyzing phospholipase D1 |
| 677 |
D07e |
0.62426 |
0.92416 |
0.13227 |
integrin alpha 1 (ITGA1); laminin & collagen receptor; VLA1; CD49A antigen |
| 452 |
C05d |
0.62429 |
1.1047 |
0.18253 |
growth arrest & DNA-damage-inducible protein 153 (GADD153); DNA-damage-inducible transcript 3 (DDIT3); C/EBP homologous protein (CHOP) |
| 393 |
C01a |
0.62431 |
0.89943 |
0.17542 |
WSL protein + TRAMP + Apo-3 + death domain receptor 3 (DDR3) |
| 779 |
D14i |
0.62537 |
1.1108 |
0.19392 |
cysteine-rich fibroblast growth factor receptor ; Golgi membrane sialoglycoprotein MG160 (GLG1) |
| 992 |
F01l |
0.62802 |
0.92841 |
0.12632 |
P37NB |
| 526 |
C10h |
0.62803 |
1.189 |
0.33357 |
DNA recombination & repair protein HNGS1 |
| 460 |
C05l |
0.63079 |
0.87455 |
0.22328 |
retinoic acid receptor gamma 1 (RAR-gamma 1; RARG) |
| 175 |
A13g |
0.63129 |
1.1442 |
0.25707 |
PIG11 |
| 136 |
A10j |
0.6314 |
1.189 |
0.33699 |
extracellular signal-regulated kinase 4 (ERK4); MAP kinase 4 (MAPK4; p63-MAPK); PRKM4 |
| 1090 |
F08l |
0.63781 |
0.90947 |
0.16473 |
KIAA0151 |
| 8 |
A01h |
0.63914 |
1.2051 |
0.3748 |
interferon-inducible protein 9-27 |
| 193 |
A14k |
0.64006 |
0.91516 |
0.1555 |
membrane-associated kinase MYT1) |
| 426 |
C03f |
0.64125 |
0.83945 |
0.29538 |
replication factor C 38-kDa subunit (RFC38); activator 1 38-kDa subunit |
| 782 |
D14l |
0.64198 |
0.85894 |
0.26013 |
frizzled homolog (FZD3) |
| 440 |
C04f |
0.64323 |
0.87352 |
0.23419 |
activator 1 37-kDa subunit; replication factor C 37-kDa subunit (RFC37); RFC4 |
| 378 |
B13n |
0.64324 |
0.86291 |
0.25384 |
retinoic acid receptor epsilon (RAR-epsilon); retinoic acid receptor beta 2 (RAR-beta2; RARB); HAP |
| 544 |
C11l |
0.6441 |
0.91143 |
0.16444 |
major histocompatibility complex enhancer-binding protein MAD3 |
| 762 |
D13f |
0.64485 |
1.1541 |
0.28673 |
plexin-related protein (PLEXR) |
| 841 |
E05a |
0.64657 |
0.86881 |
0.24553 |
bone morphogenetic protein 3 (BMP3); osteogenin |
| 298 |
B08d |
0.64726 |
0.91198 |
0.1651 |
phosphorylase B kinase gamma catalytic chain testis isoform (PHK-gamma-T; PHKGT); PSK-C3 |
| 1180 |
G27 |
0.6493 |
1.1069 |
0.20194 |
liver glyceraldehyde 3-phosphate dehydrogenase (GAPDH) |
| 579 |
C14e |
0.64967 |
1.0585 |
0.11061 |
replication protein A 70-kDa subunit (RPA70; REPA1; RF-A); single-stranded DNA-binding protein |
| 600 |
D01l |
0.64981 |
1.198 |
0.37446 |
low-affinity immunoglobulin Fc receptor beta (beta-Fc-gamma-RIII) |
| 930 |
E11f |
0.65025 |
0.82967 |
0.32262 |
interleukin-5 precursor (IL-5); T-cell replacing factor (TRF); eosinophil differentiation factor; B-cell differentiation factor I |
| 1167 |
F14e |
0.65221 |
0.90757 |
0.1762 |
BIGH3 |
| 1159 |
F13k |
0.65469 |
0.88838 |
0.21452 |
glycyl tRNA synthetase |
| 1053 |
F06c |
0.65486 |
0.85597 |
0.27694 |
dihydroorotate dehydrogenase precursor; dihydroorotate oxidase |
| 1122 |
F11b |
0.65859 |
1.1247 |
0.24278 |
phosphoribosyl pyrophosphate synthetase subunit I |
| 438 |
C04d |
0.65986 |
1.0612 |
0.11965 |
cellular apoptosis susceptibility protein (CAS); chromosome segregation gene homolog |
| 859 |
E06e |
0.65986 |
1.2141 |
0.41848 |
SDF1A; pre-B cell stimulating factor homolog |
| 1143 |
F12i |
0.66024 |
0.90265 |
0.19055 |
ribonuclease 6 precursor |
| 553 |
C12g |
0.66078 |
1.1663 |
0.32607 |
Rad50 |
| 432 |
C03l |
0.66102 |
0.8986 |
0.19899 |
MAD4 homolog |
| 464 |
C06b |
0.66162 |
0.93316 |
0.13144 |
caspase-2 precursor (CASP2); ICH-1L protease + ICH-1S protease |
| 278 |
B06l |
0.66259 |
1.2077 |
0.40966 |
calmegin |
| 1171 |
F14i |
0.66294 |
1.1695 |
0.33476 |
RNA helicase |
| 254 |
B05b |
0.66371 |
1.1302 |
0.25775 |
SH3-binding protein 2 |
| 36 |
A03h |
0.66677 |
1.1181 |
0.23629 |
interferon-inducible protein AIM2 |
| 494 |
C08d |
0.66964 |
0.87852 |
0.24543 |
inhibitor of apoptosis protein 3 (API3; IAP3); X-linked inhibitor of apotosis protein (X-linked IAP; XIAP); IAP-like protein (HILP) |
| 928 |
E11d |
0.67056 |
0.90488 |
0.19276 |
heparin-binding growth factor 2 precursor (HBGF2); prostatropin; basic fibroblast growth factor (BFGF; FGFB; FGF2) |
| 1081 |
F08c |
0.67068 |
0.93947 |
0.12273 |
GMP synthase; glutamine amidotransferase; GMP synthetase |
| 394 |
C01b |
0.67133 |
0.8397 |
0.32572 |
tumor necrosis factor type 2 receptor associated protein (TRAP3) |
| 577 |
C14c |
0.67329 |
1.0702 |
0.1436 |
interferon-inducible RNA-dependent protein kinase (P68 kinase) |
| 766 |
D13j |
0.67431 |
1.1478 |
0.30337 |
oncostatin M-specific receptor beta subunit |
| 960 |
E13h |
0.67469 |
0.89117 |
0.2237 |
Wnt-5A |
| 58 |
A05b |
0.67586 |
1.1704 |
0.35162 |
transforming growth factor beta receptor III precursor (TGF beta receptor III; TGFR3); betaglycan |
| 118 |
A09f |
0.67746 |
1.1239 |
0.25719 |
T-lymphoma invasion and metastasis inducing TIAM1 |
| 270 |
B06d |
0.67796 |
0.94848 |
0.1071 |
lipid-activated protein kinase PRK1;PKN cell morphology-related protein kinase |
| 260 |
B05h |
0.67867 |
1.2011 |
0.41915 |
NDR protein kinase |
| 824 |
E03l |
0.67895 |
0.93342 |
0.13887 |
cysteine protease |
| 585 |
C14k |
0.67958 |
1.1068 |
0.22326 |
cAMP-responsive element modulator 1 alpha protein (HCREM) |
| 99 |
A08a |
0.68142 |
1.0861 |
0.18105 |
p53 cellular tumor antigen |
| 1049 |
F05m |
0.68297 |
0.92294 |
0.16302 |
menin |
| 673 |
D07a |
0.68413 |
1.1471 |
0.31234 |
DNA cytosine-5-methyltransferase (DNA metase; MCMT) |
| 333 |
B10k |
0.68568 |
0.85844 |
0.30231 |
interferon-induced guanylate-binding protein 2; guanine nucleotide-binding protein 2 |
| 699 |
D08m |
0.68692 |
0.86744 |
0.28435 |
microsomal glutathione S-transferase II (microsomal GSTII) |
| 327 |
B10e |
0.6874 |
0.87537 |
0.26779 |
rac-beta serine/threonine kinase (rac-PK-beta); akt2 |
| 1153 |
F13e |
0.68896 |
0.86787 |
0.28548 |
"5,6-dihydroxyindole-2-carboxylic acid oxidase precursor (DHICA oxidase); tyrosinase-related protein 1 (TRP-1); catalase B; glycoprotein-75 (GP75)" |
| 268 |
B06b |
0.69068 |
1.0999 |
0.21712 |
IL-1 receptor accessory protein |
| 314 |
B09f |
0.69219 |
0.89042 |
0.2395 |
serine/threonine protein kinase |
| 321 |
B09m |
0.69228 |
1.1095 |
0.23935 |
leukemia inhibitory factor precursor (LIF); differentiation-stimulating factor (D factor); melanoma-derived LPL inhibitor (MLPLI); HILDA |
| 430 |
C03j |
0.69346 |
0.91819 |
0.17963 |
BRCA1-associated ring domain protein (BARD1) |
| 324 |
B10b |
0.69374 |
1.1381 |
0.30358 |
Abl interactor 2 (Abi-2) + Abl binding protein 3 (AblBP3) [ArgBPIB] |
| 46 |
A04d |
0.69413 |
1.0922 |
0.20286 |
pim-1 proto-oncogene |
| 1117 |
F10k |
0.69421 |
0.79449 |
0.45247 |
G-alpha interacting protein (GAIP) |
| 982 |
F01b |
0.69456 |
0.95864 |
0.091168 |
thrombospondin 1 precursor (THBS1; TSP1) |
| 614 |
D02l |
0.69512 |
1.1059 |
0.23389 |
signaling lymphocytic activation molecule |
| 406 |
C01n |
0.69814 |
0.9713 |
0.064093 |
fuse-binding protein 3 (FBP3) |
| 649 |
D05e |
0.69873 |
0.95325 |
0.10462 |
integrin alpha 6 precursor (ITGA6); VLA6; CD49F antigen |
| 292 |
B07l |
0.70092 |
1.2572 |
0.58016 |
placental calcium-binding protein; calvasculin; S100 calcium-binding protein A4; MTS1 protein |
| 481 |
C07e |
0.70189 |
1.1372 |
0.31073 |
HSIAH2 |
| 894 |
E08l |
0.7019 |
0.93535 |
0.14637 |
ubiquitin-conjugating enzyme E2 32-kDa complementing protein; ubiquitin-protein ligase; ubiquitin carrier protein; CDC34 |
| 566 |
C13f |
0.70194 |
1.1395 |
0.31594 |
Ku 70-kDa subunit; ATP-dependent DNA helicase II 70-kDa subunit; lupus ku autoantigen protein P70; thyroid-lupus auto-antigen (TLAA); CTC box binding factor 75-kDa subunit (CTC75) |
| 862 |
E06h |
0.70204 |
1.1657 |
0.3754 |
angiopoietin 1 |
| 818 |
E03f |
0.70376 |
1.1377 |
0.31388 |
interferon gamma precursor (IFN-gamma; IFNG); immune interferon |
| 739 |
D11k |
0.70572 |
0.924 |
0.17453 |
probable G protein-coupled receptor GPR4; GPR19 |
| 281 |
B07a |
0.7079 |
0.95713 |
0.09925 |
insulin-like growth factor binding protein 6 precursor (IGF-binding protein 6; IGFBP6; IBP6) |
| 66 |
A05j |
0.70839 |
1.0705 |
0.16353 |
cell division protein kinase 6 (CDK6); serine/threonine protein kinase PLSTIRE |
| 1079 |
F08a |
0.71025 |
1.0746 |
0.1742 |
laminin gamma 1 subunit precursor (LAMC1); laminin B2 subunit (LAMB2) |
| 512 |
C09h |
0.71152 |
1.1214 |
0.285 |
DNA mismatch repair protein MSH6; mutS alpha 160-kDa subunit; G/T mismatch binding protein (GTMBP; GTBP) |
| 12 |
A01l |
0.71155 |
1.1576 |
0.37002 |
cell division protein kinase 3 |
| 635 |
D04e |
0.71177 |
1.0314 |
0.073844 |
fibronectin receptor alpha subunit (FNRA); integrin alpha 5 (ITGA5); VLA5; CD49E antigen |
| 979 |
E14m |
0.71249 |
1.0513 |
0.12094 |
IgC mu heavy chain constant region |
| 264 |
B05l |
0.71399 |
1.0522 |
0.12373 |
calmodulin 1; delta phosphorylase kinase |
| 237 |
B03m |
0.71461 |
0.85038 |
0.3553 |
14-3-3 protein sigma; stratifin; epithelial cell marker protein 1 |
| 836 |
E04j |
0.71705 |
1.0619 |
0.14839 |
metalloprotease/disintegrin/cysteine-rich protein precursor (MDC9) |
| 343 |
B11g |
0.71744 |
0.97193 |
0.06739 |
YSK1; Ste20 & SPS1-related kinase |
| 562 |
C13b |
0.71913 |
0.93574 |
0.15526 |
interleukin-1 beta convertase precursor (IL-1BC); IL-1 beta converting enzyme (ICE); p45; caspase-1 (CASP1) |
| 119 |
A09g |
0.71942 |
1.1249 |
0.30218 |
prostate-specific membrane antigen (PSM) |
| 1075 |
F07k |
0.72614 |
1.1194 |
0.29659 |
translation initiation factor eIF-2 alpha subunit |
| 442 |
C04h |
0.7264 |
0.90089 |
0.24638 |
HHR23A; UV excision repair protein protein RAD23A |
| 1076 |
F07l |
0.72652 |
1.0684 |
0.17016 |
KIAA0086 |
| 774 |
D14d |
0.72652 |
1.0717 |
0.17831 |
integrin beta 5 subunit precursor (ITGB5) |
| 499 |
C08i |
0.72741 |
0.95545 |
0.11119 |
telomerase reverse transcriptase (hTRT) |
| 315 |
B09g |
0.72788 |
0.95015 |
0.12464 |
beta-adrenergic receptor kinase 2 (beta-ARK2) |
| 1124 |
F11d |
0.72976 |
0.90597 |
0.23688 |
thioredoxin reductase |
| 98 |
A07n |
0.72987 |
1.078 |
0.19661 |
CDC6-related protein |
| 399 |
C01g |
0.73017 |
0.92408 |
0.19158 |
DNA ligase I; polydeoxyribonucleotide synthase (ATP) (DNL1) (LIG1) |
| 1162 |
F13n |
0.73154 |
0.82008 |
0.45651 |
insulin-induced protein 1 |
| 596 |
D01h |
0.73158 |
0.89264 |
0.27245 |
desmocollin 2A/2B precursor (DSC2); desmosomal glycoprotein II/III |
| 608 |
D02f |
0.7321 |
0.9238 |
0.19378 |
40S ribosomal protein SA (RPSA); 34/67-kDa laminin receptor (LAMR1); colon carcinoma laminin-binding protein; NEM/1CHD4 |
| 563 |
C13c |
0.73283 |
0.92698 |
0.18624 |
death-associated protein kinase 1 (DAP kinase 1; DAPK1) |
| 738 |
D11j |
0.73348 |
0.96316 |
0.094199 |
interleukin-15 receptor alpha subunit precursor |
| 461 |
C05m |
0.73386 |
0.92957 |
0.18037 |
glucocorticoid receptor (GR) |
| 637 |
D04g |
0.73423 |
1.1527 |
0.39166 |
cadherin 6 precursor (CDH6); kidney cadherin (K-cadherin) |
| 311 |
B09c |
0.73473 |
0.97871 |
0.054713 |
c-jun N-terminal kinase 1 (JNK1); JNK46 |
| 834 |
E04h |
0.73562 |
0.92072 |
0.20449 |
G protein-coupled receptor kinase 6 (GPRK6; GRK6) |
| 456 |
C05h |
0.73682 |
0.86636 |
0.34641 |
ubiquitin-conjugating enzyme E2 17-kDa (UBE2A); ubiquitin-protein ligase; ubiquitin carrier protein; HR6A |
| 486 |
C07j |
0.73685 |
0.9559 |
0.11433 |
E2F-3 |
| 122 |
A09j |
0.7399 |
1.1014 |
0.26608 |
extracellular signal-regulated kinase 3 (ERK3); MAP kinase 3 (MAPK3; p97-MAPK); PRKM5 |
| 1164 |
F14b |
0.74012 |
1.1663 |
0.43692 |
aminoacylase 1 (ACY1) |
| 652 |
D05h |
0.74129 |
1.0841 |
0.22205 |
platelet-derived growth factor receptor beta subunit (PDGFRB); CD140B antigen |
| 783 |
D14m |
0.74157 |
1.0457 |
0.12078 |
acyloxyacyl hydrolase precursor |
| 164 |
A12j |
0.74223 |
1.0419 |
0.11104 |
cdc2-related protein kinase PISSLRE |
| 272 |
B06f |
0.74415 |
0.88725 |
0.30124 |
lipid-activated protein kinase 2 (PRK2) |
| 668 |
D06j |
0.74891 |
1.0704 |
0.19188 |
interferon-gamma receptor (IFNR-gamma; IFNGR1); CDW119 antigen |
| 319 |
B09k |
0.74893 |
1.0679 |
0.18509 |
interferon-induced guanylate-binding protein 1; guanine nucleotide-binding protein 1 |
| 727 |
D10m |
0.75433 |
1.0728 |
0.20316 |
betaine-homocysteine S-methyltransferase |
| 527 |
C10i |
0.75451 |
1.052 |
0.14516 |
muscle-specific DNase I-like precursor (DNase1L1; DNL1L); DNase X |
| 262 |
B05j |
0.75518 |
0.96175 |
0.1071 |
rho6 protein |
| 748 |
D12f |
0.75668 |
1.0519 |
0.14635 |
opioid-binding protein/cell adhesion molecule precursor (OBCAM); opioid-binding cell adhesion molecule (OPCML) |
| 457 |
C05i |
0.75772 |
1.222 |
0.62873 |
DNA repair protein RAD54 homolog |
| 151 |
A11k |
0.75826 |
0.9316 |
0.19414 |
cyclin-dependent kinase regulatory subunit (CKS2) |
| 833 |
E04g |
0.75848 |
0.9153 |
0.24062 |
interleukin-12 beta subunit precursor (IL-12B); cytotoxic lymphocyte maturation factor 40-kDa subunit (CLMF p40); NK cell stimulatory factor subunit 2 (NKSF2) |
| 1087 |
F08i |
0.75916 |
1.0174 |
0.049559 |
G-rich sequence factor 1 (GRSF1) |
| 505 |
C09a |
0.75964 |
1.0695 |
0.19847 |
DAXX |
| 693 |
D08g |
0.76027 |
0.87778 |
0.34999 |
protocadherin 42 precursor (PCDH42); cadherin-like protein |
| 375 |
B13k |
0.76044 |
1.062 |
0.17775 |
phosphatidylinositol 3-kinase |
| 561 |
C13a |
0.76208 |
1.1173 |
0.33857 |
TRAF5 |
| 429 |
C03i |
0.76246 |
1.0858 |
0.248 |
DNA repair protein XRCC9 |
| 539 |
C11g |
0.76259 |
1.0294 |
0.085033 |
DNA mismatch repair protein PMS2 (PMS1 protein homolog 2) |
| 741 |
D11m |
0.76278 |
1.0818 |
0.2369 |
2-oxoisovalerate dehydrogenase alpha subunit precursor; branched-chain alpha-keto acid dehydrogenase component alpha subunit (BCKDH E1-alpha) |
| 76 |
A06f |
0.76416 |
1.1168 |
0.34039 |
thrombopoietin receptor precursor (TPOR); myeloproliferative leukemia protein (MPL) |
| 873 |
E07e |
0.76604 |
1.1471 |
0.43233 |
stromal cell derived factor 1 precursor (SDF1); pre B-cell growth stimulating factor (PBSF) |
| 534 |
C11b |
0.76725 |
1.1002 |
0.29611 |
caspase-9 precursor (CASP9); ICE-like apoptotic protease 6 (ICE-LAP6); apoptotic protease MCH6; apoptotic protease activating factor 3 (APAF3) |
| 679 |
D07g |
0.7688 |
0.90622 |
0.27904 |
alpha-catenin related protein (CAPR); alpha 2 catenin (CTNNA2); alpha N-catenin |
| 940 |
E12b |
0.76944 |
1.0616 |
0.18391 |
heparin-binding EGF-like growth factor (HBEGF); diphtheria toxin receptor (DTR) |
| 590 |
D01b |
0.77107 |
1.1037 |
0.31183 |
nuclear domain 10 protein 52 (NDP52) |
| 303 |
B08i |
0.77207 |
0.98361 |
0.049505 |
dual-specificity protein phosphatase 8; HVH5 |
| 715 |
D10a |
0.77278 |
1.0847 |
0.2566 |
RPD3 protein; histone deacetylase 1 (HD1) |
| 645 |
D05a |
0.77422 |
1.1294 |
0.39488 |
cockayne syndrome group A; WD-repeat protein (CSA protein) |
| 796 |
E01l |
0.77567 |
0.95105 |
0.15036 |
TNF-alpha converting enzyme (TACEA); transmembrane metalloproteinase/disintegrin; adamalysin |
| 736 |
D11h |
0.77885 |
1.1336 |
0.41663 |
frizzled |
| 628 |
D03l |
0.77897 |
1.1176 |
0.36687 |
high affinity immunoglobulin gamma FC receptor II-A precursor (FC-gamma RI; FCRI; IgG FC receptor I); CD64 antigen |
| 683 |
D07k |
0.77946 |
0.87708 |
0.3844 |
FC-epsilon-receptor gamma subunit |
| 15 |
A02a |
0.7797 |
1.0619 |
0.19374 |
breast cancer type 2 susceptibility protein (BRCA2) |
| 951 |
E12m |
0.78103 |
1.116 |
0.36556 |
class II histocompatibility antigen M alpha subunit precursor |
| 664 |
D06f |
0.782 |
1.1713 |
0.54213 |
integrin beta 1 (ITGB1) |
| 290 |
B07j |
0.7834 |
0.96256 |
0.11934 |
ras-like protein TC10 |
| 301 |
B08g |
0.78612 |
0.96254 |
0.12097 |
mitogen-activated protein kinase P38 beta (MAP kinase P38 beta); stress-activated protein kinase 2 (SAPK2) |
| 709 |
D09i |
0.78708 |
1.0477 |
0.15483 |
OX40L receptor precursor; ACT35 antigen; TAX-transcriptionally activated glycoprotein 1 receptor; CD134 antigen |
| 1135 |
F12a |
0.78751 |
0.921 |
0.25689 |
tenascin-R |
| 889 |
E08g |
0.78858 |
0.92758 |
0.23674 |
interleukin-17 precursor (IL-17); cytotoxic T-lymphocyte-associted antigen 8 (CTLA8) |
| 904 |
E09h |
0.78897 |
1.2045 |
0.66986 |
jagged2 (JAG2) |
| 468 |
C06f |
0.78914 |
0.96147 |
0.12629 |
MCM4 DNA replication licensing factor; CDC21 homolog |
| 395 |
C01c |
0.78992 |
0.9193 |
0.26555 |
BAD protein; bcl-2 binding component 6 (BBC6); bcl-2L8 |
| 856 |
E06b |
0.78993 |
0.90403 |
0.31582 |
glial growth factor 2 precursor (GGFHPP2); neuregulin; heregulin-beta3 + neu differentiation factor + heregulin-alpha |
| 275 |
B06i |
0.79045 |
0.98368 |
0.053837 |
T-cell protein-tyrosine phosphatase (TCPTP) |
| 1113 |
F10g |
0.79071 |
1.0515 |
0.17018 |
myosin-IXB |
| 920 |
E10j |
0.79162 |
1.0441 |
0.14629 |
metalloproteinase inhibitor 1 precursor (TIMP1); erythroid potentiating activity (EPA); fibroblast collagenase inhibitor |
| 743 |
D12a |
0.7927 |
0.93843 |
0.20546 |
chromatin assembly factor 1 p48 subunit (CAF1 p48 subunit); retinoblastoma-binding protein 4 (RBBP4); RBAP48; msi1 protein homolog |
| 580 |
C14f |
0.7929 |
1.0629 |
0.21004 |
Ku (p70/p80) subunit; ATP-dependent DNA helicase II 86-kDa subunit; lupus ku autoantigen protein; thyroid-lupus autoantigen (TLAA); CTC box binding factor 85-kDa subunit (CTCBF; CTC85); nuclear factor IV |
| 1027 |
F04e |
0.7998 |
1.0378 |
0.13066 |
lysophospholipase homolog |
| 269 |
B06c |
0.80115 |
1.0274 |
0.09538 |
mitogen-activated protein kinase kinase kinase 5 (MAP/ERK kinase kinase 5; MAPKKK5; MEKK5); ASK1 |
| 433 |
C03m |
0.80348 |
1.0873 |
0.30803 |
octamer-binding transcription factor 3A (oct-3A; OTF3); POU5F1 |
| 242 |
B04d |
0.80434 |
1.0657 |
0.23283 |
Bruton's tyrosine kinase (BTK); agammaglobulinaemia tyrosine kinase (ATK); B-cell progenitor kinase (BPK) |
| 1062 |
F06l |
0.8064 |
1.0271 |
0.097231 |
KIAA0033 |
| 1172 |
F14j |
0.8078 |
1.0184 |
0.066261 |
40S ribosomal protein S16 |
| 400 |
C01h |
0.80959 |
0.93857 |
0.22393 |
DNA-repair protein XRCC1 |
| 810 |
E02l |
0.81048 |
0.93894 |
0.22369 |
lymphopain |
| 1168 |
F14f |
0.81422 |
1.0475 |
0.17779 |
type II cytoskeletal 5 keratin (KRT5); cytokeratin 5 (K5; CK5); 58-kDa cytokeratin |
| 161 |
A12g |
0.8152 |
1.0872 |
0.32792 |
PIG10 |
| 1004 |
F02j |
0.81637 |
0.952 |
0.18171 |
ELAV-like neuronal protein 1 (HEL-N1) + HEL-N2 |
| 667 |
D06i |
0.81779 |
0.91365 |
0.32949 |
macrophage-stimulating protein receptor precursor (MSP receptor); p185-RON; CD136 antigen |
| 877 |
E07i |
0.81842 |
0.94097 |
0.22605 |
matrix metalloproteinase 3 (MMP3); stromelysin 1 precursor (STMY1; SL1); transin 1 |
| 483 |
C07g |
0.8188 |
1.0947 |
0.3633 |
6-O-methylguanine-DNA methyltransferase (MGMT); methylated-DNA-protein-cysteine methyltransferase |
| 820 |
E03h |
0.81937 |
1.0676 |
0.26022 |
putative T1/ST2 receptor-bindng protein precursor |
| 812 |
E02n |
0.82059 |
1.123 |
0.47678 |
78-kDa glucose regulated protein precursor (GRP 78); immunoglobulin heavy chain binding protein (BIP) |
| 868 |
E06n |
0.82069 |
1.1205 |
0.46742 |
procollagen 1 alpha 2 subunit precursor (COL1A2) |
| 985 |
F01e |
0.82164 |
0.96438 |
0.13897 |
deoxycytidylate deaminase (dCMP deaminase) |
| 931 |
E11g |
0.82187 |
0.94844 |
0.20141 |
Wnt-13 |
| 220 |
B02j |
0.82392 |
1.0614 |
0.24272 |
RalB GTP-binding protein |
| 634 |
D04d |
0.82464 |
1.0491 |
0.19502 |
muscle cadherin precursor (M-cadherin); cadherin 14 or15 (CDH14 or CDH15) |
| 411 |
C02e |
0.82484 |
0.90597 |
0.37371 |
RATS1 |
| 230 |
B03f |
0.82568 |
0.93327 |
0.26652 |
cancellous bone osteoblast |
| 344 |
B11h |
0.8271 |
1.073 |
0.29416 |
protein phosphatase PP2A 65-kDa regulatory subunit beta (P65-beta) |
| 441 |
C04g |
0.82833 |
0.95878 |
0.16727 |
DNA excision repair protein ERCC1 |
| 396 |
C01d |
0.83017 |
1.0628 |
0.2576 |
NIK serine/threonine protein kinase |
| 742 |
D11n |
0.83213 |
1.0974 |
0.40459 |
beta NGF |
| 480 |
C07d |
0.83219 |
1.0351 |
0.14587 |
poly(ADP-ribose) polymerase (PARP; PPOL ); ADPRT; NAD+ ADP-ribosyltransferase; poly(ADP-ribose) synthetase |
| 962 |
E13j |
0.8335 |
1.0487 |
0.20396 |
glia-derived neurite-promoting factor (GDNPF) |
| 656 |
D05l |
0.83423 |
1.1185 |
0.49851 |
leukocyte IgG receptor (FC-gamma-R) |
| 863 |
E06i |
0.83468 |
0.96137 |
0.16294 |
matrix metalloproteinase 2 (MMP2); 72-kDa gelatinase A; 72-kDa type IV collagenase precursor (CLG4A); TBE-1 |
| 522 |
C10d |
0.83587 |
0.95459 |
0.19296 |
inhibitor of apoptosis protein1 (HIAP1; API1) + IAP homolog C; TNFR2-TRAF signaling complex protein 1; MIHC |
| 754 |
D12l |
0.83911 |
1.0504 |
0.21882 |
frizzled-related FrzB (FRITZ) + FrzB precursor + frezzled (FRE) |
| 194 |
A14l |
0.84032 |
1.0937 |
0.40968 |
transcription factor DP2 (Humdp2); E2F dimerization partner 2 |
| 253 |
B05a |
0.84171 |
0.9711 |
0.12749 |
insulin-like growth factor binding protein 4 precursor (IGF-binding protein 4; IGFBP4; IBP4) |
| 887 |
E08e |
0.84241 |
1.1661 |
0.73598 |
chemokine LEC precursor |
| 126 |
A09n |
0.84243 |
0.93722 |
0.27818 |
mitotic feedback control protein MADP2 homolog |
| 597 |
D01i |
0.84257 |
1.0659 |
0.2922 |
brain-derived neurotrophic factor (BDNF)/NT-3 growth factors receptor precursor; TRKB tyrosine kinase receptor; GP145-TRKB |
| 1094 |
F09b |
0.84284 |
0.95293 |
0.20913 |
nm23-H4; nucleoside-diphosphate kinase; nucleoside 5'-diphosphate phosphotransferase (NDK) |
| 1088 |
F08j |
0.84391 |
0.96746 |
0.14561 |
HSC70-interacting protein; progesterone receptor-associated P48 protein |
| 67 |
A05k |
0.8445 |
0.94056 |
0.26702 |
serine/threonine-protein kinase KKIALRE |
| 295 |
B08a |
0.84554 |
1.0427 |
0.19315 |
c-src kinase (CSK); protein-tyrosine kinase cyl |
| 348 |
B11l |
0.84774 |
0.97819 |
0.10012 |
STAT-induced STAT inhibitor 2 |
| 939 |
E12a |
0.84883 |
1.0501 |
0.23162 |
transforming growth factor-alpha (TGF-alpha; TGFA); EGF-like TGF (ETGF) |
| 380 |
B14b |
0.84995 |
0.96902 |
0.14432 |
mitogen-activated protein kinase p38 (MAP kinase p38); cytokine suppressive anti-inflammatory drug binding protein (CSAID binding protein; CSBP); MAX-interacting protein 2 (MXI2) |
| 1045 |
F05i |
0.85049 |
1.0217 |
0.10163 |
transmembrane protein 21 precursor (TMP21); S31III125 |
| 1003 |
F02i |
0.85064 |
1.0206 |
0.096263 |
lymphoid-restricted homolog of SP100 protein (LYSP100) |
| 374 |
B13j |
0.85156 |
1.0456 |
0.21474 |
guanine nucleotide-binding protein G(I)/G(S)/G(O) gamma-10 subunit |
| 214 |
B02d |
0.85404 |
0.96735 |
0.1565 |
serine/threonine-protein kinase PCTAIRE 1 (PCTK1) |
| 427 |
C03g |
0.85567 |
0.93669 |
0.3069 |
DNA ligase IV (LIG4); polydeoxyribonucleotide synthase |
| 241 |
B04c |
0.86012 |
1.0378 |
0.18946 |
dual-specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6; MAPKK 6; MKK6); MAPK/ERK kinase 6; SAPKK3 |
| 996 |
F02b |
0.86014 |
0.9543 |
0.2288 |
vitronectin precursor (VTN); serum spreading factor; S-protein |
| 414 |
C02h |
0.86095 |
0.96645 |
0.16897 |
DNA-dependent protein kinase (DNA-PK) + DNA-PK catalytic subunit (DNA-PKCS) |
| 1091 |
F08m |
0.86161 |
0.9795 |
0.10375 |
PM5 protein |
| 150 |
A11j |
0.87379 |
0.97225 |
0.15424 |
extracellular signal-regulated kinase 5 (ERK5); BMK1 kinase |
| 419 |
C02m |
0.87469 |
0.95592 |
0.24679 |
transcription factor Spi-B |
| 463 |
C06a |
0.87495 |
1.0358 |
0.2006 |
decoy receptor 2 |
| 202 |
B01f |
0.87608 |
1.0505 |
0.28589 |
KIAA0096 |
| 289 |
B07i |
0.87683 |
0.97113 |
0.16449 |
serine/threonin protein phosphatase 2B catalytic subunit gamma; calmodulin-dependent calcineurin A subunit gamma; testic-specific calcineurin catalytic subunit (CAM-PRP catalytic subunit) |
| 623 |
D03g |
0.88061 |
0.93466 |
0.38425 |
cadherin 4 (CDH4); retinal cadherin precursor (R-cadherin; RCAD) |
| 180 |
A13l |
0.88174 |
1.0241 |
0.14328 |
E2F dimerization partner 1; DRTF1-polypeptide 1 (DP1) |
| 165 |
A12k |
0.88289 |
1.0155 |
0.092839 |
aurora-related kinase 1 (ARK1) |
| 213 |
B02c |
0.8835 |
1.0241 |
0.14514 |
dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2; MAPKK 2); ERK activator kinase 2; MAPK/ERK kinase 2 (MEK2) |
| 681 |
D07i |
0.88351 |
1.0329 |
0.19832 |
serine/threonine-protein kinase receptor R3 precursor (SKR3); activin receptor-like kinase 1 (ACVRL1; ALK1); TGF-beta superfamily receptor type I (TSR1) |
| 306 |
B08l |
0.88486 |
1.0609 |
0.37167 |
allograft inflammatory factor 1 (AIF1); ionized calcium-binding adapter molecule 1 |
| 896 |
E08n |
0.88567 |
0.93313 |
0.41082 |
procollagen 3 alpha 1 subunit precursor (COL3A1) |
| 106 |
A08h |
0.88776 |
0.9668 |
0.20782 |
C-mer proto-onocogene precursor |
| 424 |
C03d |
0.88792 |
1.0645 |
0.40446 |
apoptotic protease activating factor 1 (APAF1) |
| 392 |
B14n |
0.88806 |
0.91741 |
0.51842 |
retinoic acid receptor beta (RXR-beta; RXRB) |
| 149 |
A11i |
0.89244 |
1.0398 |
0.26029 |
cyclin H (CCNH); MO15-associated protein |
| 42 |
A03n |
0.89264 |
1.0184 |
0.12079 |
peptidyl-prolyl cis-transisomerase nima-interacting 1 (PIN1) |
| 215 |
B02e |
0.89288 |
0.9748 |
0.16541 |
kinase suppressor of ras-1 (KSR1) |
| 976 |
E14j |
0.89328 |
1.0266 |
0.17544 |
matrix metalloproteinase 17 (MMP17); membrane-type matrix metalloproteinase 4 (MT-MMP4) |
| 514 |
C09j |
0.89456 |
0.97602 |
0.15995 |
octamer-binding transcription factor 1 (oct-1; OTF1); octamer binding protein NF-A1; POU2F1 |
| 135 |
A10i |
0.89476 |
1.0562 |
0.37572 |
G2/mitotic-specific cyclin G1 (CCNG1; CYCG1) |
| 308 |
B08n |
0.89482 |
1.0265 |
0.17698 |
TNF-related apoptosis inducing ligand (TRAIL); APO-2 ligand (APO2L) |
| 485 |
C07i |
0.89584 |
0.98437 |
0.10555 |
V(D)J recombination activating protein 1 (RAG1) |
| 999 |
F02e |
0.89604 |
0.95592 |
0.29817 |
cystathionine gamma-lyase |
| 445 |
C04k |
0.89676 |
0.97025 |
0.20269 |
nuclear factor kappa-B DNA binding subunit (NF-kappaB; NFKB) |
| 284 |
B07d |
0.89853 |
0.99566 |
0.030058 |
calcium/calmodulin-dependent protein kinase I (CAMKI) |
| 888 |
E08f |
0.89899 |
0.94325 |
0.39522 |
interleukin-3 precursor (IL-3); multipotential colony-stimulating factor; hematopoietic growth factor; P-cell stimulating factor; mast-cell growth factor (MCGF) |
| 942 |
E12d |
0.90024 |
0.93394 |
0.46589 |
fibroblast growth factor 3 (FGF3) ; INT2 proto-oncogene protein precursor; HBGF3 |
| 196 |
A14n |
0.90044 |
1.0535 |
0.37823 |
brain glucose transporter 3 (GTR3) |
| 879 |
E07k |
0.9016 |
0.97125 |
0.20559 |
putative ATP-dependent CLP protease proteolytic subunit mitochondrial precursor; endopeptidase CLP |
| 651 |
D05g |
0.90254 |
1.0547 |
0.39507 |
cadherin 12 (CDH12); brain cadherin precursor (Br-cadherin); neural cadherin 2 (N-cadherin 2) |
| 82 |
A06l |
0.90469 |
0.98292 |
0.12616 |
cyclin-dependent kinase 4 inhibitor (CDK4I; CDKN2); p16-INK4; multiple tumor suppressor 1 (MTS1) |
| 166 |
A12l |
0.90804 |
0.97812 |
0.16753 |
CDC25C; M-phase inducer phosphatase 3 |
| 757 |
D13a |
0.90858 |
1.0124 |
0.095192 |
chromatin assembly factor-I P150 subunit |
| 222 |
B02l |
0.90909 |
0.964 |
0.27883 |
"calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B (CAM-PDE1B); HCAM2" |
| 49 |
A04g |
0.91127 |
1.0072 |
0.056903 |
metastasis-associated protein 1 (MTA1) |
| 854 |
E05n |
0.91279 |
0.96628 |
0.27238 |
collagen 4 alpha 6 subunit precursor (COL4A6) |
| 391 |
B14m |
0.91537 |
0.95756 |
0.35333 |
diacylglycerol kinase epsilon (DGK-epsilon; DAG kinase episilon); diglyceride kinase |
| 847 |
E05g |
0.91697 |
0.95395 |
0.39081 |
interleukin-12 alpha subunit precursor (IL-12A); cytotoxic lymphocyte maturation factor 35-kDa subunit (CLMF p35); NK cell stimulatory factor subunit 1 (NKSF1) |
| 88 |
A07d |
0.91699 |
0.97388 |
0.22171 |
tyrosine-protein kinase receptor UFO precursor; axl oncogene |
| 167 |
A12m |
0.91706 |
1.0207 |
0.17629 |
CDC27HS protein |
| 408 |
C02b |
0.91955 |
0.98279 |
0.15078 |
CD27BP (Siva) |
| 144 |
A11d |
0.92109 |
1.0238 |
0.21265 |
papillary thyroid carcinoma-encoded protein + ret proto-oncogene |
| 478 |
C07b |
0.92153 |
1.0134 |
0.12073 |
caspase-3 (CASP3); apopain precursor; cysteine protease CPP32; YAMA protein; SREBP cleavage activity 1; SCA-1 |
| 422 |
C03b |
0.92267 |
0.9694 |
0.27893 |
MAP kinase-activating death domain protein |
| 291 |
B07k |
0.92512 |
1.0273 |
0.25661 |
GDI-dissociation inhibitor RhoGDIgammma |
| 24 |
A02j |
0.9268 |
0.96758 |
0.31231 |
cell division control protein 2 homolog (CDC2); p34 protein kinase; cyclin-dependent kinase 1 (CDK1) |
| 328 |
B10f |
0.92811 |
1.0222 |
0.21778 |
serine/threonine protein kinase PK428 |
| 243 |
B04e |
0.92973 |
1.0066 |
0.06584 |
DCHT |
| 558 |
C12l |
0.92995 |
1.0144 |
0.14524 |
ets-elated transcription factor E74-like factor 1 (ELF1) |
| 250 |
B04l |
0.93022 |
0.98056 |
0.19647 |
KIAA0422 |
| 109 |
A08k |
0.93086 |
1.015 |
0.15325 |
CDC-like kinase 2 (CLK2) |
| 632 |
D04b |
0.93133 |
0.98272 |
0.17757 |
DNA-binding protein UEV-1; UBE2V |
| 504 |
C08n |
0.93171 |
0.97394 |
0.26924 |
prostanoid EP1 receptor ; prostaglandin E2 receptor EP1 subtype (PGE receptor EP1; PTGER1) |
| 368 |
B13d |
0.93224 |
1.0215 |
0.22381 |
ribosomal protein S6 kinase II alpha 1 (S6KII-alpha 1); ribosomal S6 kinase 1 (RSK1) |
| 435 |
C04a |
0.93273 |
1.0305 |
0.32021 |
FAS soluble protein; Apo1 |
| 547 |
C12a |
0.93899 |
1.0076 |
0.087937 |
CD40 receptor-associated factor 1 (CRAF1) |
| 747 |
D12e |
0.93982 |
1.0503 |
0.59025 |
neural cell adhesion molecule L1 precursor (N-CAM L1); MIC5 |
| 55 |
A04m |
0.94011 |
1.001 |
0.011605 |
cyclin-dependent kinase 5 activator precursor (CDK5 activator); tau protein kinase II 23-kDa subunit; TPKII regulatory subunit |
| 915 |
E10e |
0.94075 |
0.98137 |
0.22195 |
CXC chemokine precursor |
| 177 |
A13i |
0.94198 |
1.0178 |
0.2171 |
thyrotropin-releasing hormone receptor (TRHR); thyroliberin receptor |
| 428 |
C03h |
0.94322 |
0.98959 |
0.12942 |
DNA damage repair & recombination protein 52 (RAD52) |
| 69 |
A05m |
0.94358 |
1.0167 |
0.20884 |
growth-arrest-specific protein 1 (GAS1) |
| 755 |
D12m |
0.94368 |
1.0283 |
0.35528 |
neutrophil cytosol factor 2; neutrophil NADPH oxidase factor 1 (NCF1); p47-PHOX); 47-kDa autosomal chronic granulomatous disease protein |
| 68 |
A05l |
0.94375 |
0.98654 |
0.16891 |
cyclin-dependent kinase 4 inhibitor B (CDKN2B); p14-INK4B; multiple tumor suppressor 2 (MTS2) |
| 1000 |
F02f |
0.94438 |
0.98936 |
0.13502 |
type I cytoskeletal 9 keratin; cytokeratin 9 (K9; CK 9) |
| 509 |
C09e |
0.94647 |
1.0177 |
0.23368 |
glutathione S-transferase theta 2 |
| 599 |
D01k |
0.95263 |
1.029 |
0.43212 |
urokinase-type plasminogen activator receptor GPI-anchored form precursor (U-PAR); monocyte activation antigen MO3; CD87 antigen |
| 1095 |
F09c |
0.95288 |
1.0222 |
0.33312 |
uridine phosphorylase (UDRPase; UP) |
| 65 |
A05i |
0.95375 |
0.98688 |
0.20033 |
G2/mitotic-specific cyclin B1 (CCNB1) |
| 959 |
E13g |
0.95389 |
1.0178 |
0.27254 |
ephrin-A5 precursor; EPH-related receptor tyrosine kinase ligand 7 (LERK-7); AL-1 |
| 359 |
B12i |
0.95425 |
1.013 |
0.20109 |
Gem; induced immediate early protein; ras family member (ras-like protein KIR) |
| 261 |
B05i |
0.95522 |
1.0125 |
0.19748 |
serine/threonine protein phosphatase 6 (PP6) |
| 730 |
D11b |
0.95721 |
0.97711 |
0.37785 |
bone proteoglycan II precursor (PGS2); decorin (DCN) |
| 341 |
B11e |
0.95739 |
0.99015 |
0.16338 |
C-jun N-terminal kinase kinase 2 (JNKK2); mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7; MAPKK7) |
| 300 |
B08f |
0.95921 |
1.01 |
0.17311 |
putative serine/threonine protein kinase PRK |
| 1147 |
F12m |
0.95986 |
1.0197 |
0.34592 |
AAD14 protein |
| 740 |
D11l |
0.96063 |
0.98631 |
0.24576 |
TRAIL receptor 3; decoy receptor 1 (DCR1) |
| 835 |
E04i |
0.96069 |
0.9884 |
0.20859 |
PDGF associated protein |
| 791 |
E01g |
0.96163 |
0.97793 |
0.40647 |
interleukin-13 precursor (IL-13); NC30 |
| 839 |
E04m |
0.96243 |
0.98506 |
0.28091 |
IgG receptor FC large subunit P51 precursor (FCRN); neonatal FC receptor; IgG FC fragment receptor transporter alpha chain |
| 323 |
B10a |
0.96333 |
1.0162 |
0.31267 |
70-kDa zeta-associated protein (ZAP70) |
| 248 |
B04j |
0.96456 |
1.0044 |
0.08797 |
rhoC (H9); small GTPase (rhoC) |
| 663 |
D06e |
0.96514 |
0.99296 |
0.14271 |
integrin beta 4 (ITGB4); CD104 antigen |
| 390 |
B14l |
0.96642 |
0.99633 |
0.077244 |
protein kinase C-binding protein RACK7 |
| 183 |
A14a |
0.9684 |
1.0167 |
0.37335 |
cadherin1 (CDH1); epithelial cadherin precursor (E-cadherin; CDHE); uvomorulin (UVO); CAM 120/80 |
| 353 |
B12c |
0.96904 |
1.0027 |
0.062164 |
focal adhesion kinase (FADK); proline-rich tyrosine kinase 2 (PYK2) |
| 208 |
B01l |
0.9697 |
1.0183 |
0.4264 |
phospholipase C beta 4 |
| 672 |
D06n |
0.97091 |
1.0062 |
0.14993 |
UV radiation-resistance-associated protein |
| 520 |
C10b |
0.97146 |
0.98353 |
0.40793 |
caspase-8 precursor (CASP8); ICE-like apoptotic protease 5 (ICE-LAP5); MORT1-associated CED-3 homolog (MACH); FADD-homologous ICE/CED-3-like protease (FADD-like ICE; FLICE); apoptotic cysteine protease MCH-5 |
| 867 |
E06m |
0.97303 |
1.0113 |
0.29671 |
complement component 5 (C5) |
| 908 |
E09l |
0.97367 |
1.0051 |
0.13808 |
basigin precursor (BSG); leukocyte activation antigen M6; collagenase stimulatory factor; extracellular matrix metalloproteinase inducer (EMMPRIN); 5F7; CD147 antigen |
| 506 |
C09b |
0.97428 |
0.99431 |
0.15651 |
caspase-6 precursor (CASP6); cysteine protease MCH2 isoforms alpha + beta |
| 658 |
D05n |
0.97455 |
0.99387 |
0.17026 |
chitinase precursor |
| 511 |
C09g |
0.97577 |
1.0139 |
0.40425 |
xeroderma pigmentosum group G complementing protein (XPG); DNA excision repair protein ERCC5 |
| 255 |
B05c |
0.97584 |
1.0054 |
0.15688 |
MAPK/ERK kinase kinase 3 (MEK kinase 3; MEKK3) |
| 228 |
B03d |
0.97746 |
0.99274 |
0.22771 |
tyrosine-protein kinase tec |
| 1178 |
G13 |
0.97918 |
0.99366 |
0.21541 |
phospholipase A2 |
| 1039 |
F05c |
0.97983 |
0.99461 |
0.18883 |
cytidine deaminase (CDA) |
| 342 |
B11f |
0.98183 |
0.99687 |
0.1217 |
serine/threonine protein kinase PRP4 homolog |
| 548 |
C12b |
0.98185 |
0.99141 |
0.33465 |
caspase-10 precursor (CASP10); ICE-LIKE apoptotic protease 4 (ICE-LAP4); apoptotic protease MCH4; fas-associated death domain protein; interleukin-1-beta-converting enzyme 2 (FLICE2) |
| 550 |
C12d |
0.98472 |
1.0077 |
0.35694 |
apoptosis-related protein TFAR15 |
| 455 |
C05g |
0.98599 |
0.9978 |
0.11116 |
xeroderma pigmentosum group D complementing protein (XPD); DNA excision repair protein ERCC2 |
| 925 |
E11a |
0.9863 |
0.99837 |
0.084054 |
osteoclast stimulating factor |
| 821 |
E03i |
0.98653 |
0.9973 |
0.14181 |
CYR61 protein |
| 204 |
B01h |
0.9885 |
0.99547 |
0.27849 |
protein kinase DYRK4 |
| 948 |
E12j |
0.98956 |
1.0037 |
0.25207 |
tissue inhibtor of mettaloproteinase 4 (TIMP4) |
| 92 |
A07h |
0.99055 |
1.0078 |
0.58292 |
MDM2-like p53-binding protein (MDMX) |
| 458 |
C05j |
0.99299 |
0.9984 |
0.16145 |
serum response factor (SRF) |
| 775 |
D14e |
0.99309 |
1.001 |
0.10058 |
hemopoietic progenitor cell CD34 antigen precursor |
| 495 |
C08e |
0.99482 |
0.99799 |
0.27365 |
maleylacetoacetate isomerase (MAAI); glutathione transferase zeta 1 |
| 633 |
D04c |
0.99759 |
1.0007 |
0.20658 |
melanoma antigen P15 |
| 120 |
A09h |
0.99832 |
1.0011 |
0.47663 |
P126 (ST5) |
| 778 |
D14h |
0.9998 |
0.99988 |
0.43404 |
high-affinity nerve growth factor receptor precursor; trk-1 transforming tyrosine kinase protein; p140-TRKA; p68-trk-T3 oncoprotein |